https://curecurrent.com/trials/the-tolerability-of-saracatinib-in-subjects-with-lymphangioleiomyomatosis-lam-slam-1-52001https://curecurrent.com/trials/afatinib-expanded-access-program-52002https://curecurrent.com/trials/efficacy-safety-of-imprime-pgg-with-cetuximab-paclitaxel-carboplatin-therapy-in-pts-with-untreated-advanced-non-small-ce-52003https://curecurrent.com/trials/phase-ii-trial-of-sbrt-compared-with-conventional-radiotherapy-for-oligometastatic-non-small-cell-lung-cancer-52004https://curecurrent.com/trials/sbrt-combination-with-rhgm-csf-and-t-1-for-stage-iv-nsclc-patients-who-failed-in-second-line-chemotherapy-52005https://curecurrent.com/trials/mk2206-and-erlotinib-hydrochloride-in-treating-patients-with-advanced-non-small-cell-lung-cancer-who-have-progressed-aft-52006https://curecurrent.com/trials/pharmacogenomic-study-in-patients-of-lung-colorectal-and-head-neck-cancers-receiving-chemotherapy-52007https://curecurrent.com/trials/minimally-invasive-endoscopy-in-diffuse-lung-disease-52008https://curecurrent.com/trials/a-study-of-pemetrexed-plus-cisplatin-with-concurrent-radiation-therapy-followed-by-docetaxel-consolidation-in-patients-w-52009https://curecurrent.com/trials/evaluation-of-pd1-pdl1-expression-on-blood-cells-tumor-tissue-their-role-as-a-prognostic-target-in-nsclc-patients-52010https://curecurrent.com/trials/radiotherapy-combined-with-thymosin-for-metastatic-nsclc-patients-who-showed-stable-disease-after-first-line-tki-therapy-52011https://curecurrent.com/trials/early-incorporation-of-patient-and-family-to-attention-and-care-program-in-oncology-versus-standard-of-care-52012https://curecurrent.com/trials/post-marketing-surveillance-study-of-docetaxel-based-chemotherapy-52013https://curecurrent.com/trials/safety-tolerability-pharmacokinetics-and-anti-tumour-activity-of-ac0010-in-advanced-non-small-cell-lung-cancer-52014https://curecurrent.com/trials/open-label-prospective-study-to-investigate-efficacy-and-safety-of-azd9291-in-bm-from-nsclc-patients-with-egfr-t790m-52015https://curecurrent.com/trials/extensive-stage-sclc-patients-who-were-benefit-from-first-line-treatment-accept-temozolomide-maintain-therapeutic-52016https://curecurrent.com/trials/upar-pet-for-prognostication-in-patients-with-non-small-cell-lung-cancer-malignant-pleural-mesothelioma-and-large-cell-n-52017https://curecurrent.com/trials/high-dose-icotinib-treatment-beyond-progression-in-egfr-mutant-nsclc-52018https://curecurrent.com/trials/study-investigating-the-effect-of-everolimus-monotherapy-in-patients-with-advanced-non-small-cell-lung-cancer-nsclc-52019https://curecurrent.com/trials/azacitidine-and-entinostat-in-treating-patients-with-newly-diagnosed-stage-ia-iiia-non-small-lung-cancer-undergoing-surg-52020https://curecurrent.com/trials/dynamic-pet-ct-as-a-tool-for-treatment-efficacy-monitoring-in-lung-cancer-52021https://curecurrent.com/trials/bibf-1120-docetaxel-japan-in-patients-with-advanced-non-small-cell-lung-cancer-phase-i-52022https://curecurrent.com/trials/the-value-of-vocs-analysis-in-exhaled-breath-for-pulmonary-benign-and-malignant-lesion-diagnosis-52023https://curecurrent.com/trials/the-role-of-sedation-technique-in-ebus-tbna-52024https://curecurrent.com/trials/icotinib-in-non-small-cell-lung-cancer-patients-with-uncommon-egfr-mutation-52025https://curecurrent.com/trials/lux-lung-special-access-scheme-australia-named-patient-use-npu-52026https://curecurrent.com/trials/a-study-of-ro5083945-in-combination-with-cisplatin-and-gemcitabine-or-carboplatin-and-paclitaxel-in-patients-with-advanc-52027https://curecurrent.com/trials/to-demonstrate-equivalence-in-analgesic-efficacy-bowel-function-between-oxn-pr-higher-dose-lower-dose-tablet-strengths-i-52028https://curecurrent.com/trials/efficacy-study-of-aurolase-therapy-in-subjects-with-primary-and-or-metastatic-lung-tumors-52029https://curecurrent.com/trials/a-c-in-metastatic-lung-adenocarcinoma-cancer-52030https://curecurrent.com/trials/a-study-of-avastin-bevacizumab-in-patients-with-non-squamous-non-small-cell-lung-cancer-nsclc-52031https://curecurrent.com/trials/a-study-of-onartuzumab-metmab-in-combination-with-tarceva-erlotinib-in-participants-with-met-diagnostic-positive-non-sma-52032https://curecurrent.com/trials/an-observational-study-of-tarceva-erlotinib-in-first-line-in-patients-with-advanced-egfr-mutation-positive-non-small-cel-52033https://curecurrent.com/trials/an-observational-study-on-patients-with-non-squamous-nsclc-who-reached-a-long-pfs-after-avastin-bevacizumab-based-first-52034https://curecurrent.com/trials/a-study-of-onartuzumab-in-combination-with-erlotinib-in-patients-with-met-positive-stage-iiib-or-iv-non-small-cell-lung-52035https://curecurrent.com/trials/an-observational-study-of-tarceva-erlotinib-in-routine-practice-for-first-line-maintenance-therapy-in-patients-with-non-52036https://curecurrent.com/trials/application-of-detecting-circulating-tumor-cells-in-the-accurate-treatment-of-early-stage-lung-adenocarcinoma-52037https://curecurrent.com/trials/an-observational-study-of-lung-cancer-related-symptoms-and-disease-control-rate-in-patients-with-non-small-cell-lung-can-52038https://curecurrent.com/trials/an-observational-study-of-tarceva-erlotinib-in-previously-treated-patients-with-advanced-non-small-cell-lung-cancer-with-52039https://curecurrent.com/trials/an-observational-study-of-avastin-bevacizumab-in-combination-with-chemotherapy-in-patients-with-metastatic-or-recurrent-52040https://curecurrent.com/trials/a-study-of-avastin-bevacizumab-in-combination-with-thoracic-radiation-and-chemotherapy-in-patients-with-advanced-non-squ-52041https://curecurrent.com/trials/an-observational-study-of-tarceva-erlotinib-in-patients-with-non-small-cell-lung-cancer-52042https://curecurrent.com/trials/a-study-of-the-safety-and-pharmacology-of-gdc-0941-in-combination-with-erlotinib-in-patients-with-advanced-solid-tumors-52043https://curecurrent.com/trials/rituximab-in-combination-with-fludarabine-and-cyclophosphamide-in-patients-with-chronic-lymphocytic-leukemia-52044https://curecurrent.com/trials/pepita-study-an-observational-study-of-tarceva-erlotinib-in-second-line-in-patients-with-locally-advanced-or-metastatic-52045https://curecurrent.com/trials/a-study-of-the-safety-and-pharmacology-of-pi3-kinase-inhibitor-gdc-0941-in-combination-with-either-paclitaxel-and-carbop-52046https://curecurrent.com/trials/an-exploratory-study-of-ro4929097-in-patients-with-recurrent-or-refractory-non-small-cell-lung-cancer-52047https://curecurrent.com/trials/a-feasibility-trial-of-avastin-bevacizumab-in-combination-with-concomitant-chemoradiation-cisplatin-and-vinorelbine-in-p-52048https://curecurrent.com/trials/a-genetic-substudy-associated-with-the-avastin-bevacizumab-study-mo19390-in-patients-with-advanced-or-recurrent-non-squa-52049https://curecurrent.com/trials/study-evaluating-the-safety-and-efficacy-of-megf0444a-in-combination-with-carboplatin-paclitaxel-and-bevacizumab-in-pati-52050https://curecurrent.com/trials/dynamic-changes-of-circulating-tumor-dna-in-late-stage-nsclc-patients-52051https://curecurrent.com/trials/is-there-any-relation-between-serum-anti-p53-antibody-and-tlg-mtv-and-suv-as-pet-parameters-in-lung-cancer-patients-52052https://curecurrent.com/trials/chemotherapy-plus-gefitinib-for-advanced-lung-adenocarcinoma-and-sensitive-egfr-mutations-a-randomized-controlled-trial-52053https://curecurrent.com/trials/exercise-for-stable-myasthenia-gravis-52054https://curecurrent.com/trials/adam-afatinib-diarrhea-assessment-and-management-52055https://curecurrent.com/trials/erlotinib-hydrochloride-and-quinacrine-dihydrochloride-in-stage-iiib-iv-non-small-cell-lung-cancer-52056https://curecurrent.com/trials/imaging-with-11c-erlotinib-pet-ct-to-identify-responders-to-erlotinib-treatment-in-nsclc-52057https://curecurrent.com/trials/a-study-of-first-line-maintenance-erlotinib-versus-erlotinib-at-disease-progression-in-participants-with-advanced-non-sm-52058https://curecurrent.com/trials/collecting-tumor-samples-from-patients-with-gynecological-tumors-52059https://curecurrent.com/trials/precision-diagnosis-for-intraoperative-frozen-section-of-early-stage-lung-cancer-52060https://curecurrent.com/trials/alk-ros1-met-mutations-on-plasma-ctdna-in-patients-with-nsclc-52061https://curecurrent.com/trials/distress-and-quality-of-life-during-the-diagnostic-phase-of-a-suspected-serious-lung-disease-52062https://curecurrent.com/trials/methylation-level-of-shox2-in-endobronchial-ultrasound-with-real-time-guided-transbronchial-needle-aspiration-for-lung-c-52063https://curecurrent.com/trials/prevalence-of-spontaneous-pneumothorax-in-bhd-52064https://curecurrent.com/trials/endobronchial-ultrasound-transbronchial-needle-aspiration-ebus-tbna-sample-division-52065https://curecurrent.com/trials/cancer-vaccine-study-for-stage-iii-unresectable-non-small-cell-lung-cancer-nsclc-in-the-asian-population-52066https://curecurrent.com/trials/sym004-in-subjects-with-stage-iv-non-small-cell-lung-cancer-52067https://curecurrent.com/trials/tivantinib-in-treating-patients-with-previously-treated-malignant-mesothelioma-52068https://curecurrent.com/trials/micro-rna-genetic-signature-in-nsclc-egyptian-patients-52069https://curecurrent.com/trials/lung-cancer-symptom-assessment-and-management-intervention-52070https://curecurrent.com/trials/18f-fdg-metabolism-imaging-monitoring-non-small-cell-lung-cancer-curative-effect-of-chemotherapy-multicenter-clinical-st-52071https://curecurrent.com/trials/investigate-the-safety-and-tolerability-of-azd6244-monotherapy-or-docetaxel-in-japanese-patients-with-advanced-solid-mal-52072https://curecurrent.com/trials/systemic-chemotherapy-combined-with-recombinant-human-adenovirus-type-5-and-endostatin-injections-for-treatment-malignan-52073https://curecurrent.com/trials/erlotinib-in-post-radical-operation-nsclc-patients-with-egfr-mutation-52074https://curecurrent.com/trials/precision-diagnosis-and-therapy-for-early-stage-lung-cancer-52075https://curecurrent.com/trials/lombardi-comprehensive-cancer-center-legacy-pilot-study-to-reduce-adverse-smoking-outcomes-in-the-context-of-lung-cancer-52076https://curecurrent.com/trials/analysis-of-p-selectin-expression-on-platelets-of-blood-from-lung-cancer-patients-52077https://curecurrent.com/trials/clinical-study-of-chemotherapy-combined-with-chinese-medicine-on-survival-affect-of-elderly-patients-with-lung-cancer-52078https://curecurrent.com/trials/single-pulmonary-nodule-investigation-52079https://curecurrent.com/trials/predictive-value-of-fdg-tep-during-radiotherapy-or-chemo-radiotherapy-in-patients-with-ncsc-on-the-one-year-survival-52080https://curecurrent.com/trials/zactima-in-non-small-cell-lung-cancer-nsclc-elderly-patients-in-combination-with-or-versus-gemcitabine-52081https://curecurrent.com/trials/uniportal-versus-triportal-thoracoscopic-lobectomy-and-sublobectomy-for-early-stage-lung-cancer-52082https://curecurrent.com/trials/one-time-injection-of-bacteria-to-treat-solid-tumors-that-have-not-responded-to-standard-therapy-52083https://curecurrent.com/trials/gefitinib-combined-with-chemotherapy-or-antiangiogensis-in-patients-with-bim-deletion-or-low-egfr-mutation-abundance-52084https://curecurrent.com/trials/pazopanib-and-paclitaxel-for-non-small-cell-lung-cancer-52085https://curecurrent.com/trials/comparison-of-efficacy-and-safety-of-the-postoperative-analgesia-methods-52086https://curecurrent.com/trials/memory-and-mri-changes-with-hippocampus-avoidance-prophylactic-cranial-irradiation-ha-pci-for-small-cell-lung-cancer-scl-52087https://curecurrent.com/trials/phase-ii-of-zactima-maintenance-for-locally-advanced-or-metastatic-non-small-cell-lung-carcinoma-nsclc-following-platinu-52088https://curecurrent.com/trials/could-the-stroke-volume-variation-predict-a-fluid-responsiveness-in-thoracotomy-52089https://curecurrent.com/trials/precision-cell-immunotherapy-combined-with-chemotherapy-in-advanced-lung-cancer-52090https://curecurrent.com/trials/pemetrexed-disodium-carboplatin-and-radiation-therapy-with-or-without-cetuximab-in-treating-patients-with-stage-iii-non-52091https://curecurrent.com/trials/common-safety-follow-up-trial-of-tecemotide-l-blp25-52092https://curecurrent.com/trials/open-label-study-in-patients-with-metastatic-nslc-treated-with-cisplatin-gemcitabine-and-bevacizumab-52093https://curecurrent.com/trials/an-expanded-access-program-of-tarceva-erlotinib-in-participants-with-advanced-non-small-cell-lung-cancer-nsclc-52094https://curecurrent.com/trials/pemetrexed-plus-bevacizumab-in-non-small-cell-lung-cancer-52095https://curecurrent.com/trials/oral-chemotherapy-and-platinum-with-radiotherapy-followed-or-not-by-consolidation-with-the-same-chemotherapy-in-locally-52096https://curecurrent.com/trials/paclitaxel-carboplatin-plus-bevacizumab-in-pretreated-advanced-or-metastatic-non-small-cell-lung-cancer-52097https://curecurrent.com/trials/dexmedetomidine-and-hypoxic-pulmonary-vasoconstriction-in-thoracic-surgical-procedures-and-one-lung-ventilation-52098https://curecurrent.com/trials/metronomic-vinorelbine-and-bevacizumab-in-patients-with-non-small-cell-lung-cancer-52099https://curecurrent.com/trials/docetaxel-plus-bevacizumab-in-metastatic-non-small-cell-lung-cancer-52100https://curecurrent.com/trials/zd6474-zactima-phase-iii-study-in-egfr-failures-52101https://curecurrent.com/trials/rapid-learning-for-lung-cancer-52102https://curecurrent.com/trials/a-single-dose-pilot-study-of-radiolabeled-amatuximab-morab-009-in-mesothelin-over-expressing-cancers-52103https://curecurrent.com/trials/metformin-in-stage-iv-lung-adenocarcinoma-52104https://curecurrent.com/trials/zactima-an-anti-egfr-anti-vegf-agent-combined-with-docetaxel-compared-to-docetaxel-in-non-small-cell-lung-cancer-52105https://curecurrent.com/trials/pemetrexed-plus-cetuximab-in-patients-with-recurrent-non-small-cell-lung-cancer-52106https://curecurrent.com/trials/integrative-analysis-of-large-cell-lung-cancer-52107https://curecurrent.com/trials/a-study-of-dkn-01-in-multiple-myeloma-or-advanced-solid-tumors-52108https://curecurrent.com/trials/neoadjuvant-concurrent-chemoradiation-with-weekly-docetaxel-cisplatin-for-resectable-iiia-n2-nsclc-52109https://curecurrent.com/trials/effect-of-different-anesthetics-on-the-change-of-alarmins-in-lung-cancer-patients-receiving-pulmonary-lobectomy-52110https://curecurrent.com/trials/in-vivo-egfr-ecd-molecular-imaging-using-68ga-labelling-anti-egfr-affibody-molecule-52111https://curecurrent.com/trials/autologous-tumor-dribble-vaccine-in-patients-with-non-small-cell-lung-cancer-52112https://curecurrent.com/trials/detection-of-oncogenic-tumor-mutations-in-the-urine-and-blood-of-lung-and-colorectal-cancer-patients-52113https://curecurrent.com/trials/detecting-egfr-t790m-mutations-from-circulating-tumor-cells-52114https://curecurrent.com/trials/circulating-tumor-cells-spillage-after-pulmonary-biopsy-52115https://curecurrent.com/trials/individualized-lung-recruitment-maneuver-guide-by-pulse-oximetry-in-anesthetized-patients-52116https://curecurrent.com/trials/motivational-counseling-in-preventing-smoking-relapse-after-pregnancy-in-pregnant-women-who-quit-smoking-during-pregnanc-52117https://curecurrent.com/trials/a-study-of-onartuzumab-metmab-in-combination-with-bevacizumab-avastin-plus-platinum-and-paclitaxel-or-with-pemetrexed-pl-52118https://curecurrent.com/trials/evaluation-of-symptoms-improvement-in-nsclc-patients-with-first-line-therapy-of-egfr-tyrosine-kinase-inhibitor-52119https://curecurrent.com/trials/etiologies-investigations-and-outcomes-of-patients-presenting-with-hemoptysis-52120https://curecurrent.com/trials/a-study-comparing-irinotecan-and-cisplatin-ip-with-etoposide-and-cisplatin-ep-following-ep-trt-for-ld-sclc-52121https://curecurrent.com/trials/trial-of-drainage-with-or-without-bleomycin-instillation-for-malignant-pericardial-effusion-52122https://curecurrent.com/trials/study-of-preoperative-docetaxel-or-cisplatin-cddp-docetaxel-for-c-stage-ib-ii-non-small-cell-lung-cancer-nsclc-52123https://curecurrent.com/trials/carboplatin-paclitaxel-bevacizumab-and-vorinostat-for-patients-with-advanced-non-small-cell-lung-cancer-52124https://curecurrent.com/trials/trial-of-pre-operative-chemoradiotherapy-followed-by-surgical-resection-in-pancoast-tumors-jcog-9806-52125https://curecurrent.com/trials/a-phase-ii-study-of-stereotactic-body-radiation-therapy-in-patients-with-t1n0m0-non-small-cell-lung-cancer-jcog0403-52126https://curecurrent.com/trials/effect-of-ttfields-150khz-in-non-small-cell-lung-cancer-nsclc-patients-with-1-5-brain-metastases-following-optimal-stand-52127https://curecurrent.com/trials/rct-comparing-19ga-vs-22ga-ebus-tbna-needles-in-carcinoma-52128https://curecurrent.com/trials/study-on-the-influence-of-fluoroscopy-in-the-diagnosis-of-peripheral-lung-lesions-with-endobronchial-ultrasound-guidance-52129https://curecurrent.com/trials/urinary-circulating-tumor-dna-detection-in-non-small-cell-lung-cancer-a-prospective-study-52130https://curecurrent.com/trials/pi3k-inhibitor-bkm120-carboplatin-and-pemetrexed-disodium-in-treating-patients-with-stage-iv-non-small-cell-lung-cancer-52131https://curecurrent.com/trials/trial-of-bi-6727-volasertib-monotherapy-and-bi-6727-in-combination-with-pemetrexed-compared-to-pemetrexed-monotherapy-in-52132https://curecurrent.com/trials/surgical-treatment-of-elderly-patients-with-ct1n0m0-non-small-cell-lung-cancer-comparison-between-sublobar-resection-and-52133https://curecurrent.com/trials/evaluation-of-the-effects-of-a-mixture-of-amino-acids-amixea-on-lean-body-mass-and-muscle-strengh-of-patients-with-unres-52134https://curecurrent.com/trials/thymosin-alpha-1-plus-maintenance-therapy-with-the-standard-of-care-soc-in-patients-with-metastatic-non-small-cell-lung-52135https://curecurrent.com/trials/study-comparing-weekly-taxol-and-carboplatin-vs-standard-taxol-and-carboplatin-regimen-for-stage-iiib-or-iv-non-small-ce-52136https://curecurrent.com/trials/first-line-bio-immunotherapy-with-thymosin-alpha-1-in-patients-with-sensitizing-egfr-mutation-positive-non-small-cell-lu-52137https://curecurrent.com/trials/validation-of-a-kinetic-model-of-erlotinib-52138https://curecurrent.com/trials/validation-of-the-mick-assay-52139https://curecurrent.com/trials/is-clarithromycin-a-potential-treatment-for-cachexia-in-people-with-lung-cancer-52140https://curecurrent.com/trials/lux-lung-2-phase-ii-single-arm-bibw-2992-afatinib-in-nsclc-with-egfr-activating-mutations-52141https://curecurrent.com/trials/a-study-to-assess-the-survival-of-non-small-cell-lung-cancer-patients-treated-with-tarceva-after-failed-chemotherapy-tre-52142https://curecurrent.com/trials/immunomagnetic-detection-of-cancer-cells-in-pleural-effusion-in-lung-cancer-patients-as-additional-staging-and-prognosti-52143https://curecurrent.com/trials/regional-anesthesia-and-lung-cancer-recurrence-52144https://curecurrent.com/trials/detection-of-ctcs-in-patients-undergoing-surgery-for-stage-iv-colorectal-cancer-52145https://curecurrent.com/trials/early-stage-lung-cancer-screening-with-low-dose-computed-tomographic-52146https://curecurrent.com/trials/chemoresistance-and-involvement-of-the-notch-pathway-in-patients-with-lung-adenocarcinoma-52147https://curecurrent.com/trials/cognitive-testing-of-tobacco-use-measurement-items-for-administration-with-cancer-patients-and-survivors-52148https://curecurrent.com/trials/elderly-nsclc-d-vs-dp-jcog0207-52149https://curecurrent.com/trials/molecular-diagnosis-on-circulating-tumor-dna-of-non-small-cell-lung-cancer-52150https://curecurrent.com/trials/yoga-in-improving-quality-of-life-in-patients-with-non-small-cell-lung-cancer-undergoing-treatment-52151https://curecurrent.com/trials/pleurectomy-decortication-with-intraoperative-intrathoracic-intraperitoneal-heated-cisplatin-with-sodium-thiosulfate-52152https://curecurrent.com/trials/phase-ii-bevacizumab-gemcitabine-and-carboplatin-in-newly-diagnosed-non-small-cell-lung-cancer-52153https://curecurrent.com/trials/precision-cell-immunotherapy-combined-with-tace-in-advanced-liver-cancer-52154https://curecurrent.com/trials/a-study-of-onartuzumab-metmab-versus-placebo-in-combination-with-paclitaxel-plus-platinum-in-patients-with-squamous-non-52155https://curecurrent.com/trials/effect-of-low-molecular-weight-heparin-tinzaparin-in-lung-tumours-tilt-52156https://curecurrent.com/trials/a-phase-i-study-of-recombinant-hgm-csf-herpes-simplex-virus-to-treat-cancer-52157https://curecurrent.com/trials/tf2-small-cell-lung-cancer-radio-immunotherapy-52158https://curecurrent.com/trials/nabilone-effect-on-the-attenuation-of-anorexia-nutritional-status-and-quality-of-life-in-lung-cancer-patients-52159https://curecurrent.com/trials/first-line-icotinib-with-concurrent-radiotherapy-for-nsclc-with-egfr-mutation-52160https://curecurrent.com/trials/hepasphere-interventional-therapy-using-digital-subtraction-angiography-dsa-for-lung-cancer-52161https://curecurrent.com/trials/investigate-the-maximum-tolerated-dose-of-vandetanib-and-concurrent-whole-brain-radiotherapy-wbrt-in-patients-with-non-s-52162https://curecurrent.com/trials/phase-i-combination-with-vinorelbine-or-gemcitabine-plus-cisplatin-in-locally-advanced-or-metastatic-nsclc-52163https://curecurrent.com/trials/auranofin-and-sirolimus-in-treating-patients-with-advanced-solid-tumors-or-recurrent-non-small-cell-lung-cancer-52164https://curecurrent.com/trials/zd6474-phase-iia-dose-finding-multicentre-study-52165https://curecurrent.com/trials/phase-trial-of-wbrt-versus-erlotinib-concurrent-whole-brain-radiation-therapy-as-first-line-treatment-for-patients-with-52166https://curecurrent.com/trials/efficacy-safety-immunogenicity-study-of-cbt124-eu-sourced-avastin-in-stage-4-nsclc-52167https://curecurrent.com/trials/this-study-is-to-assess-the-efficacy-and-safety-of-zd6474-in-subjects-with-non-small-cell-lung-cancer-52168https://curecurrent.com/trials/zd6474-vandetanib-alimta-combo-study-52169https://curecurrent.com/trials/zd6474-alone-or-in-combination-with-paclitaxel-and-carboplatin-in-subjects-with-previously-untreated-locally-advanced-or-52170https://curecurrent.com/trials/pd-1-antibody-expressing-car-t-cells-for-egfr-family-member-positive-advanced-solid-tumor-lung-liver-and-stomach-52171https://curecurrent.com/trials/a-study-of-first-or-second-line-treatment-with-tarceva-erlotinib-in-patients-with-advanced-non-small-cell-lung-cancer-52172https://curecurrent.com/trials/registry-study-of-thoracic-reirradiation-for-non-small-cell-lung-cancer-nsclc-utilizing-proton-beam-therapy-or-intensity-52173https://curecurrent.com/trials/this-study-is-to-compare-the-efficacy-of-zd6474-and-zd1839-in-subjects-with-nsclc-52174https://curecurrent.com/trials/zd6474-in-treating-patients-with-small-cell-lung-cancer-52175https://curecurrent.com/trials/study-of-the-quality-of-lung-resection-52176https://curecurrent.com/trials/apatinib-as-the-maintenance-therapy-for-extensive-stage-small-cell-lung-cancer-after-combined-with-etoposide-cisplatin-52177https://curecurrent.com/trials/a-study-of-avastin-bevacizumab-in-combination-with-platinum-based-chemotherapy-in-patients-with-advanced-or-recurrent-sq-52178https://curecurrent.com/trials/a-study-of-mm-121-combination-therapy-in-patients-with-advanced-non-small-cell-lung-cancer-52179https://curecurrent.com/trials/detection-of-circulating-endothelial-progenitors-cells-epcs-in-non-small-cell-lung-cancer-nsclc-52180https://curecurrent.com/trials/feasibility-study-to-estimate-number-of-patients-with-precancerous-areas-in-their-airways-and-the-response-to-gefitinib-52181https://curecurrent.com/trials/safety-study-of-dacarbazine-and-bortezomib-in-melanoma-and-soft-tissue-sarcoma-52182https://curecurrent.com/trials/safety-and-pharmacology-study-of-snx-5422-in-subjects-with-resistant-lung-adenocarcinoma-52183https://curecurrent.com/trials/a-phase-2-pilot-study-of-apixaban-for-the-prevention-of-thromboembolic-events-in-patients-with-advanced-metastatic-cance-52184https://curecurrent.com/trials/microwave-ablation-for-pulmonary-metastases-from-colorectal-cancer-52185https://curecurrent.com/trials/dasatinib-in-treating-patients-with-previously-treated-malignant-mesothelioma-52186https://curecurrent.com/trials/preliminary-study-of-microwave-tumoral-ablation-performances-for-the-treatment-of-pulmonary-renal-and-bone-neoplasia-52187https://curecurrent.com/trials/a-study-of-mircera-in-anemic-patients-with-non-small-cell-lung-cancer-receiving-first-line-chemotherapy-52188https://curecurrent.com/trials/early-lung-cancer-detection-using-computed-tomography-52189https://curecurrent.com/trials/an-open-label-phase-ib-ii-study-of-bay-1000394-roniciclib-in-combination-with-docetaxel-in-second-or-third-line-treatmen-52190https://curecurrent.com/trials/irinotecan-carboplatin-and-radiation-therapy-followed-by-bevacizumab-in-limited-stage-small-cell-lung-cancer-52191https://curecurrent.com/trials/egfr-tki-with-chemotherapy-in-nsclc-patients-with-both-egfr-mutation-and-bim-deletion-polymorphism-52192https://curecurrent.com/trials/lepirudin-in-treating-patients-with-recurrent-or-advanced-small-cell-lung-cancer-52193https://curecurrent.com/trials/a-study-of-erlotinib-tarceva-in-participants-with-non-small-cell-lung-cancer-nsclc-52194https://curecurrent.com/trials/trial-of-rnactive-derived-cancer-vaccine-and-local-radiation-in-in-stage-iv-non-small-cell-lung-cancer-nsclc-52195https://curecurrent.com/trials/apatinib-combined-with-docetaxel-monotherapy-as-second-line-therapy-of-advanced-egfr-wt-non-squamous-nsclc-52196https://curecurrent.com/trials/talactoferrin-in-treating-patients-with-relapsed-or-refractory-non-small-cell-lung-cancer-or-squamous-cell-head-and-neck-52197https://curecurrent.com/trials/palliative-care-teaching-sessions-for-family-caregivers-of-patients-with-non-small-cell-lung-cancer-52198https://curecurrent.com/trials/temozolomide-for-relapsed-sensitive-or-refractory-small-cell-lung-cancer-52199https://curecurrent.com/trials/enhancement-of-neurocognitive-functions-by-hippocampal-sparing-radiotherapy-52200https://curecurrent.com/trials/perceptions-and-representations-of-cancer-chemotherapy-52201https://curecurrent.com/trials/phase-2-trial-of-durvalumab-with-or-without-bavituximab-in-patients-with-previously-treated-metastatic-non-small-cell-lu-52202https://curecurrent.com/trials/immunotherapy-with-racotumomab-in-advanced-lung-cancer-52203https://curecurrent.com/trials/radiotherapy-dose-complement-in-the-treatment-of-hypoxic-lesions-patients-with-stage-iii-non-small-cell-lung-cancer-52204https://curecurrent.com/trials/efficacy-of-sofosbuvir-with-ribavirin-administered-pre-transplant-in-preventing-hepatitis-c-virus-hcv-recurrence-post-tr-52205https://curecurrent.com/trials/molecular-analysis-of-150-lung-adenocarcinoma-52206https://curecurrent.com/trials/bibw-2992-and-bsc-versus-placebo-and-bsc-in-non-small-cell-lung-cancer-patients-failing-erlotinib-or-gefitinib-lux-lung-52207https://curecurrent.com/trials/cisplatin-etoposide-radiotherapy-followed-by-consolidation-sorafenib-for-inoperable-stage-iii-non-small-cell-lung-cancer-52208https://curecurrent.com/trials/intensity-modulated-radiotherapy-imrt-with-simultaneous-integrated-boost-sib-for-inoperable-non-small-cell-lung-cancer-52209https://curecurrent.com/trials/clinical-and-pathologic-studies-of-patients-undergoing-treatment-with-egfr-inhibitors-52210https://curecurrent.com/trials/safety-and-efficacy-of-obatoclax-mesylate-gx15-070ms-in-combination-with-docetaxel-for-the-treatment-of-non-small-cell-l-52211https://curecurrent.com/trials/a-phase-i-ii-study-of-carboplatin-and-etoposide-with-or-without-obatoclax-in-extensive-stage-small-cell-lung-cancer-es-s-52212https://curecurrent.com/trials/crizotinib-efficacy-in-non-small-cell-lung-cancer-patients-with-anaplastic-lymphoma-kinase-translocation-52213https://curecurrent.com/trials/cisplatin-plus-etoposide-with-or-without-paclitaxel-in-treating-patients-with-extensive-stage-small-cell-lung-cancer-52214https://curecurrent.com/trials/carboplatin-paclitaxel-and-radiation-therapy-in-treating-patients-with-stage-iii-non-small-cell-lung-cancer-that-cannot-52215https://curecurrent.com/trials/utility-of-endobronchial-ultrasound-guided-needle-biopsy-in-early-stage-non-small-cell-lung-cancer-nsclc-52216https://curecurrent.com/trials/gemcitabine-plus-docetaxel-or-irinotecan-in-treating-patients-with-stage-iiib-or-stage-iv-non-small-cell-lung-cancer-52217https://curecurrent.com/trials/liposomal-sn-38-in-treating-patients-with-small-cell-lung-cancer-52218https://curecurrent.com/trials/irofulven-in-treating-patients-with-relapsed-or-refractory-non-small-cell-lung-cancer-52219https://curecurrent.com/trials/chemotherapy-plus-radiation-therapy-in-treating-patients-with-limited-stage-small-cell-lung-cancer-52220https://curecurrent.com/trials/diagnostic-study-for-lung-cancer-detection-test-52221https://curecurrent.com/trials/combination-chemotherapy-and-radiation-therapy-in-treating-patients-with-limited-stage-small-cell-lung-cancer-52222https://curecurrent.com/trials/karenitecin-in-treating-patients-with-relapsed-or-refractory-non-small-cell-lung-cancer-52223https://curecurrent.com/trials/combination-chemotherapy-and-computer-planned-radiation-therapy-in-treating-patients-with-unresectable-stage-iii-non-sma-52224https://curecurrent.com/trials/mature-dendritic-cell-vaccination-against-unique-immunogenic-peptides-in-patients-with-non-small-cell-lung-cancer-nsclc-52225https://curecurrent.com/trials/evaluation-of-a-powered-surgical-stapler-in-video-assisted-thoracoscopic-lung-resection-procedures-in-korea-52226https://curecurrent.com/trials/cixutumumab-everolimus-and-octreotide-acetate-in-treating-patients-with-advanced-low-to-intermediate-grade-neuroendocrin-52227https://curecurrent.com/trials/combination-chemotherapy-in-treating-patients-with-recurrent-or-refractory-small-cell-lung-cancer-52228https://curecurrent.com/trials/thoracoscopy-in-patients-with-stage-iiia-non-small-cell-lung-cancer-52229https://curecurrent.com/trials/carboplatin-and-paclitaxel-in-treating-older-patients-with-metastatic-or-recurrent-unresectable-non-small-cell-lung-canc-52230https://curecurrent.com/trials/radiation-therapy-in-treating-patients-with-stage-i-non-small-cell-lung-cancer-and-lung-dysfunction-52231https://curecurrent.com/trials/capecitabine-in-treating-patients-with-malignant-mesothelioma-52232https://curecurrent.com/trials/azd9291-us-expanded-access-program-52233https://curecurrent.com/trials/lymph-node-removal-in-treating-patients-with-stage-i-or-stage-ii-non-small-cell-lung-cancer-52234https://curecurrent.com/trials/radiotherapy-planning-based-on-positron-emission-tomography-with-fluoro-deoxyglucose-for-advanced-nsclc-52235https://curecurrent.com/trials/video-assisted-surgery-followed-by-radiation-therapy-in-treating-patients-with-stage-i-non-small-cell-lung-cancer-and-po-52236https://curecurrent.com/trials/paclitaxel-in-treating-patients-with-extensive-stage-small-cell-lung-cancer-52237https://curecurrent.com/trials/docetaxel-and-gemcitabine-in-treating-patients-with-stage-iiib-or-stage-iv-non-small-cell-lung-cancer-52238https://curecurrent.com/trials/topotecan-paclitaxel-and-filgrastim-in-treating-patients-with-previously-untreated-extensive-stage-small-cell-lung-cance-52239https://curecurrent.com/trials/comparison-of-nicotine-inhaler-and-or-bupropion-in-helping-people-to-stop-smoking-and-prevent-the-recurrence-of-smoking-52240https://curecurrent.com/trials/pain-management-smartphone-application-for-patients-with-stage-iii-iv-head-and-neck-cancer-undergoing-radiation-therapy-52241https://curecurrent.com/trials/combination-chemotherapy-with-or-without-radiation-therapy-in-treating-patients-with-stage-iiia-non-small-cell-lung-canc-52242https://curecurrent.com/trials/efficacy-study-of-chinese-medicine-plus-egfr-tki-versus-egfr-tki-in-advanced-pulmonary-adenocarcinoma-52243https://curecurrent.com/trials/positron-emission-tomography-for-detecting-non-small-cell-lung-cancer-52244https://curecurrent.com/trials/donepezil-and-vitamin-e-to-prevent-side-effects-caused-by-radiation-therapy-to-the-head-in-patients-receiving-treatment-52245https://curecurrent.com/trials/vinorelbine-in-treating-older-patients-with-stage-iiib-or-stage-iv-non-small-cell-lung-cancer-52246https://curecurrent.com/trials/topotecan-and-paclitaxel-in-treating-patients-with-recurrent-or-refractory-small-cell-lung-cancer-52247https://curecurrent.com/trials/study-of-aerosolized-sargramostim-in-treating-patients-with-melanoma-metastatic-to-the-lung-52248https://curecurrent.com/trials/sargramostim-in-treating-patients-with-kidney-cancer-that-has-spread-to-the-lung-52249https://curecurrent.com/trials/phase-1-erlotinib-and-dovitinib-tki258-in-advanced-non-small-cell-lung-cancer-nsclc-52250https://curecurrent.com/trials/conventional-or-video-assisted-surgery-in-treating-patients-with-lung-metastases-52251https://curecurrent.com/trials/responses-to-chemotherapy-of-patients-with-non-small-cell-lung-cancer-harboring-a-known-somatic-activating-her2-mutation-52252https://curecurrent.com/trials/management-of-malignant-pleural-effusion-indwelling-pleural-catheter-or-talc-pleurodesis-52253https://curecurrent.com/trials/ct-in-diagnosing-patients-with-lung-cancer-52254https://curecurrent.com/trials/a-study-of-gefitinib-with-or-without-apatinib-in-patients-with-advanced-non-squamous-non-small-cell-lung-cancer-harborin-52255https://curecurrent.com/trials/irinotecan-with-docetaxel-in-treating-patients-with-recurrent-or-metastatic-non-small-cell-lung-cancer-52256https://curecurrent.com/trials/gemcitabine-hydrochloride-and-carboplatin-with-or-without-mk-0646-as-first-line-therapy-in-treating-patients-with-stage-52257https://curecurrent.com/trials/biomarkers-in-tissue-and-blood-samples-from-patients-with-early-stage-non-small-cell-lung-cancer-52258https://curecurrent.com/trials/pemetrexed-disodium-and-carboplatin-in-treating-patients-with-extensive-stage-small-cell-lung-cancer-52259https://curecurrent.com/trials/pemetrexed-disodium-and-bevacizumab-in-treating-patients-with-stage-iii-or-stage-iv-non-small-cell-lung-cancer-52260https://curecurrent.com/trials/cisplatin-and-irinotecan-followed-by-carboplatin-etoposide-and-radiation-therapy-in-treating-patients-with-limited-stage-52261https://curecurrent.com/trials/a-study-to-evaluate-the-good-and-bad-effects-of-bibf1120-in-small-cell-lung-cancer-patients-who-have-previously-benefite-52262https://curecurrent.com/trials/cetuximab-and-radiation-therapy-in-treating-patients-with-stage-iii-non-small-cell-lung-cancer-52263https://curecurrent.com/trials/multidisciplinary-education-in-lung-cancer-patients-who-receiving-chemotherapy-treatment-52264https://curecurrent.com/trials/inhaled-sargramostim-in-treating-patients-with-melanoma-metastatic-to-the-lung-52265https://curecurrent.com/trials/combination-chemotherapy-and-radiation-therapy-in-treating-patients-with-limited-stage-small-cell-lung-cancer-52266https://curecurrent.com/trials/proteomic-profiling-in-diagnosing-non-small-cell-lung-cancer-in-patients-who-are-undergoing-lung-resection-for-suspiciou-52267https://curecurrent.com/trials/a-study-of-prevalence-of-egfr-mutations-in-participants-with-nsclc-52268https://curecurrent.com/trials/combination-chemotherapy-plus-fluoxetine-in-treating-patients-with-advanced-or-recurrent-non-small-cell-lung-cancer-52269https://curecurrent.com/trials/descriptive-pharmacoepidemiological-study-of-patients-treated-with-iressa-52270https://curecurrent.com/trials/standard-chest-tube-compared-with-a-small-catheter-in-treating-malignant-pleural-effusion-in-patients-with-cancer-52271https://curecurrent.com/trials/breath-analysis-for-evaluation-of-radiation-exposure-in-lung-cancer-patients-treated-with-radiation-52272https://curecurrent.com/trials/ptk787-zk-222584-in-treating-patients-with-unresectable-malignant-mesothelioma-52273https://curecurrent.com/trials/a-phase-3-study-of-ganetespib-in-combination-with-docetaxel-versus-docetaxel-alone-in-patients-with-advanced-nsclc-52274https://curecurrent.com/trials/the-role-of-audiovisual-biofeedback-on-image-quality-during-4d-anatomic-and-functional-imaging-52275https://curecurrent.com/trials/paclitaxel-with-or-without-carboplatin-in-treating-patients-with-advanced-non-small-cell-lung-cancer-52276https://curecurrent.com/trials/carboplatin-and-gemcitabine-combined-with-celecoxib-and-or-zileuton-in-treating-patients-with-advanced-non-small-cell-lu-52277https://curecurrent.com/trials/sentinel-lymph-node-mapping-in-detecting-cancer-that-has-spread-to-lymph-nodes-in-patients-with-non-small-cell-lung-canc-52278https://curecurrent.com/trials/docetaxel-and-cisplatin-with-or-without-dimesna-in-treating-patients-with-stage-iiib-or-stage-iv-non-small-cell-lung-can-52279https://curecurrent.com/trials/combined-modality-treatment-for-resectable-non-small-cell-superior-sulcus-tumors-52280https://curecurrent.com/trials/phase-ii-study-of-dasatinib-in-previously-treated-patients-with-advanced-nsclc-52281https://curecurrent.com/trials/the-role-of-icotinib-in-the-perioperative-treatment-of-iiia-iiib-nsclc-patients-with-egfr-mutation-52282https://curecurrent.com/trials/detection-of-early-metastases-in-patients-with-stage-i-non-small-cell-lung-cancer-52283https://curecurrent.com/trials/cancer-genome-study-using-samples-from-patients-with-stage-i-or-stage-ii-non-small-cell-lung-cancer-treated-on-clinical-52284https://curecurrent.com/trials/epidermal-growth-factor-receptor-and-k-ras-mutations-in-patients-with-stage-iii-non-small-cell-lung-cancer-52285https://curecurrent.com/trials/chemotherapy-and-radiation-in-treating-participants-with-stage-3-non-small-cell-lung-cancer-52286https://curecurrent.com/trials/chidamide-with-egfr-tki-for-advanced-egfr-tki-resistant-non-small-cell-lung-cancer-52287https://curecurrent.com/trials/study-of-tissue-samples-from-patients-with-stage-i-non-small-cell-lung-cancer-enrolled-on-research-study-calgb-140202-52288https://curecurrent.com/trials/dasatinib-and-erlotinib-in-non-small-cell-lung-cancer-nsclc-52289https://curecurrent.com/trials/efficacy-study-of-integrated-tcm-combined-with-chemotherapy-in-postoperative-nsclc-patients-52290https://curecurrent.com/trials/a-study-of-gemcitabine-cisplatin-chemotherapy-plus-necitumumab-in-the-first-line-treatment-of-participants-with-squamous-52291https://curecurrent.com/trials/study-of-18f-fluoro-peg6-ipqa-52292https://curecurrent.com/trials/a-study-of-first-line-treatment-with-tarceva-erlotinib-in-combination-with-gemcitabine-in-patients-with-unresectable-adv-52293https://curecurrent.com/trials/drug-drug-interaction-study-with-azd9291-and-omeprazole-in-healthy-volunteers-52294https://curecurrent.com/trials/postoperative-rehabilitation-in-operation-for-lung-cancer-proluca-52295https://curecurrent.com/trials/personalized-adaptive-radiation-therapy-with-individualized-systemic-targeted-therapy-partist-for-locally-advanced-non-s-52296https://curecurrent.com/trials/mitigation-of-radiation-pneumonitis-fibrosis-and-heart-toxicity-with-nicorandil-in-lung-cancer-patients-52297https://curecurrent.com/trials/treatment-of-cancer-anorexia-using-megestrol-acetate-concentrated-suspension-in-lung-or-pancreatic-cancer-patients-52298https://curecurrent.com/trials/radical-lung-radiotherapy-plus-nelfinavir-52299https://curecurrent.com/trials/acquired-resistant-mechanism-of-the-first-generation-egfr-tkis-52300https://curecurrent.com/trials/determine-mtd-and-to-evaluate-pk-safety-tolerability-and-efficacy-profiles-of-hocena-in-nsclc-subjects-52301https://curecurrent.com/trials/endostar-durative-transfusion-combined-with-chemotherapy-in-the-treatment-of-advanced-lung-adenocarcinoma-52302https://curecurrent.com/trials/manometry-vs-clinical-assessment-in-the-detection-of-trapped-lung-in-patients-with-suspected-pleural-malignancy-52303https://curecurrent.com/trials/peg-rhg-csf-in-patients-with-malignant-solid-tumors-receiving-chemotherapy-52304https://curecurrent.com/trials/a-multi-center-prospective-observational-biomarker-study-on-egfrm-non-small-cell-lung-cancer-patients-with-leptomeningea-52305https://curecurrent.com/trials/pemetrexed-plus-cisplatin-versus-gemcitabine-plus-cisplatin-for-advanced-nsclc-metastatic-non-small-cell-lung-cancer-52306https://curecurrent.com/trials/a-study-of-amg-951-rhapo2l-trail-in-subjects-with-previously-untreated-non-small-cell-lung-cancer-nsclc-treated-with-che-52307https://curecurrent.com/trials/phase-ii-pilot-study-of-2nd-generation-anti-cea-designer-t-cells-in-adenocarcinomas-52308https://curecurrent.com/trials/a-placebo-controlled-study-comparing-azd1775-docetaxel-versus-placebo-docetaxel-to-treat-lung-cancer-52309https://curecurrent.com/trials/identification-of-marker-of-primary-or-acquired-resistance-to-anti-tumorous-treatment-52310https://curecurrent.com/trials/study-of-psychopathological-characteristics-of-patient-smoking-in-thoracic-oncology-52311https://curecurrent.com/trials/tolerability-and-efficacy-of-tremelimumab-in-combination-with-gefitinib-in-nsclc-patients-52312https://curecurrent.com/trials/individualized-adaptive-radiotherapy-based-on-pet-ct-and-imrt-for-locally-advanced-non-small-cell-lung-cancer-nsclc-52313https://curecurrent.com/trials/phase-1b-2-trial-of-amg386-with-pemetrexed-and-carboplatin-in-non-small-cell-lung-cancer-52314https://curecurrent.com/trials/a-study-of-hypofractionated-radiotherapy-for-limited-metastatic-nsclc-harboring-sensitizing-egfr-mutations-after-first-l-52315https://curecurrent.com/trials/iressa-v-bsc-best-supportive-care-in-first-line-nsclc-52316https://curecurrent.com/trials/vascularity-impact-on-the-treatment-outcome-in-malignant-pleural-mesothelioma-vitmpm-52317https://curecurrent.com/trials/influence-of-the-use-of-the-diabetic-drug-metformin-on-the-overall-survival-and-treatment-related-toxicity-in-advanced-s-52318https://curecurrent.com/trials/monosialoganglioside-gm1-preventing-neurotoxicity-induced-by-cisplatin-contained-chemotherapy-in-nsclc-patients-52319https://curecurrent.com/trials/sorave-sorafenib-and-everolimus-in-solid-tumors-52320https://curecurrent.com/trials/brain-irradiation-in-treating-patients-with-limited-stage-small-cell-lung-cancer-52321https://curecurrent.com/trials/d-cik-combined-with-chemotherapy-for-non-small-cell-lung-cancer-nsclc-52322https://curecurrent.com/trials/epidemiological-study-to-describe-non-small-cell-lung-cancer-clinical-management-patterns-in-mena-lung-epiclin-gulf-52323https://curecurrent.com/trials/a-study-of-avastin-bevacizumab-in-combination-with-platinum-containing-chemotherapy-in-patients-with-advanced-or-recurre-52324https://curecurrent.com/trials/a-study-of-metronidazole-cream-in-the-prevention-and-treatment-of-tarceva-erlotinib-associated-rash-52325https://curecurrent.com/trials/apatinib-plus-docetaxel-as-2nd-line-treatment-in-patients-with-advanced-non-squamous-and-non-small-cell-lung-cancer-52326https://curecurrent.com/trials/italian-lung-cancer-screening-trial-italung-52327https://curecurrent.com/trials/molecular-imaging-with-erlotinib-and-bevacizumab-52328https://curecurrent.com/trials/conmana-combined-with-thalidomide-to-treat-nsclc-52329https://curecurrent.com/trials/phase-ii-study-of-zd6474-in-advanced-nsclc-52330https://curecurrent.com/trials/pilot-and-feasibility-study-of-the-imaging-potential-of-ec17-intraoperative-folate-fluorescein-conjugate-ec17-lung-cance-52331https://curecurrent.com/trials/temozolomide-as-maintenance-therapy-following-induction-chemotherapy-in-extensive-stage-small-cell-lung-cancer-52332https://curecurrent.com/trials/study-to-evaluate-kos-1584-in-patients-with-advanced-or-metastatic-stage-iiib-iv-non-small-cell-lung-cancer-nsclc-52333https://curecurrent.com/trials/rociletinib-genomic-landscape-in-non-small-cell-lung-cancer-nsclc-52334https://curecurrent.com/trials/clinical-randomized-study-of-concurrent-chemo-radiotherapy-vs-radiotherapy-alone-to-local-advanced-small-cell-lung-cance-52335https://curecurrent.com/trials/clinical-study-of-three-plus-two-type-early-diagnosis-of-pulmonary-nodules-in-medical-internet-of-things-52336https://curecurrent.com/trials/right-side-of-heart-function-after-lung-surgery-52337https://curecurrent.com/trials/a-study-of-tarceva-erlotinib-and-gemcitabine-in-treatment-naive-patients-with-advanced-non-small-cell-lung-cancer-52338https://curecurrent.com/trials/selinexor-in-treating-patients-with-relapsed-small-cell-lung-cancer-52339https://curecurrent.com/trials/docetaxel-combined-with-cisplatin-as-first-line-in-patients-with-metastatic-non-small-cell-lung-cancer-52340https://curecurrent.com/trials/experience-of-erlotinib-in-patients-with-advanced-non-small-cell-lung-cancer-52341https://curecurrent.com/trials/cyclin-dependent-kinase-cdk-4-6-inhibitor-pd0332991-in-advanced-non-small-cell-lung-cancer-nsclc-52342https://curecurrent.com/trials/electromagnetic-navigational-bronchoscopy-vs-transthoracic-needle-biopsy-for-the-sampling-of-peripheral-lung-nodules-52343https://curecurrent.com/trials/study-on-systemic-and-airway-cytokines-and-oxidative-stress-in-lung-cancer-patients-undergoing-surgery-52344https://curecurrent.com/trials/pharmacology-study-of-aerosolized-liposomal-52345https://curecurrent.com/trials/carboplatin-pemetrexed-and-panitumumab-in-patients-with-advanced-non-squamous-k-ras-wild-type-nsclc-52346https://curecurrent.com/trials/a-phase-1-study-in-participants-with-advanced-cancer-52347https://curecurrent.com/trials/clinical-efficacy-and-safety-of-dendritic-cytotoxic-lymphocyte-dc-ctl-cell-infusion-in-nsclc-patients-52348https://curecurrent.com/trials/tarceva-surgery-for-resectable-stage-iiia-n2-and-iiib-t4-n2-non-small-cell-lung-cancer-52349https://curecurrent.com/trials/systemic-therapy-with-or-without-upfront-transarterial-embolization-for-inoperable-liver-metastasis-of-neuroendocrine-tu-52350https://curecurrent.com/trials/a-phase-i-study-of-sunitinib-and-rapamycin-in-advanced-non-small-cell-lung-cancer-nsclc-52351https://curecurrent.com/trials/a-trial-of-amrubicin-and-carboplatin-with-pegfilgrastim-in-patients-with-extensive-stage-small-cell-lung-cancer-52352https://curecurrent.com/trials/safety-tolerability-and-pharmacokinetics-of-quisinostat-a-histone-deacetylase-inhibitor-in-combination-with-chemotherapy-52353https://curecurrent.com/trials/blood-hair-and-lung-concentrations-of-metals-and-metalloids-in-patients-with-lung-cancer-or-chronic-obstructive-pulmonar-52354https://curecurrent.com/trials/blood-collection-from-individuals-with-lung-disease-for-genetic-studies-qatar-52355https://curecurrent.com/trials/gated-intensity-modulated-radiation-therapy-and-concurrent-chemotherapy-for-inoperable-nsclc-52356https://curecurrent.com/trials/blood-collection-from-individuals-with-lung-disease-for-genetic-studies-52357https://curecurrent.com/trials/the-evaluation-of-lung-cancer-patient-treated-with-epidermal-growth-factor-receptor-tyrosine-kinase-52358https://curecurrent.com/trials/ipilimumab-induced-lung-toxicity-observational-study-52359https://curecurrent.com/trials/pemetrexed-and-radiation-for-poor-risk-stage-iii-non-small-cell-lung-cancer-52360https://curecurrent.com/trials/the-efficacy-of-5-fluorouracil-mitomycin-for-the-patients-with-pulmonary-metastasis-of-hepatocellular-carcinoma-52361https://curecurrent.com/trials/chemotherapy-resistance-and-sensitivity-testing-in-lung-tumors-52362https://curecurrent.com/trials/sclc-on-the-2nd-line-with-relapsed-after-response-to-chemotherapy-gfpc-01-2013-52363https://curecurrent.com/trials/a-study-of-obinutuzumab-in-chinese-participants-with-cd20-malignant-disease-52364https://curecurrent.com/trials/combination-of-chemotherapy-and-gefitinib-as-first-line-treatment-52365https://curecurrent.com/trials/phase-ii-avastin-trial-for-stage-iiib-iv-nsclc-52366https://curecurrent.com/trials/neurocognitive-function-after-prophylactic-cranial-irradiation-hippocampal-sparing-in-ld-sclc-patients-a-pilot-study-52367https://curecurrent.com/trials/pulmonary-artery-harmonic-ace-7-energy-sealing-in-vats-lobectomy-52368https://curecurrent.com/trials/a-study-comparing-bevacizumab-therapy-with-or-without-erlotinib-for-first-line-treatment-of-non-small-cell-lung-cancer-a-52369https://curecurrent.com/trials/a-study-of-bind-014-docetaxel-nanoparticles-for-injectable-suspension-as-second-line-therapy-for-patients-with-kras-posi-52370https://curecurrent.com/trials/a-phase-2-study-to-determine-the-safety-and-efficacy-of-bind-014-docetaxel-nanoparticles-for-injectable-suspension-as-se-52371https://curecurrent.com/trials/a-comparison-between-ebus-gs-and-ct-guided-lung-biopsy-in-diagnosis-of-peripheral-pulmonary-lesions-52372https://curecurrent.com/trials/can-epidermal-growth-factor-receptor-improve-the-postoperative-survivorship-for-inoperable-non-small-cell-lung-cancer-wi-52373https://curecurrent.com/trials/multiple-portal-vats-versus-uniportal-vats-lobectomy-for-non-small-cell-lung-cancer-52374https://curecurrent.com/trials/fractionated-versus-target-controlled-propofol-administration-in-bronchoscopy-52375https://curecurrent.com/trials/detection-cell-free-dna-in-lung-cancer-patients-52376https://curecurrent.com/trials/rt-plus-egfr-tki-for-wild-type-nsclc-52377https://curecurrent.com/trials/the-effect-on-decreasing-chemotherapeutic-toxicity-and-increasing-anti-tumor-effect-of-chinese-herbs-based-on-syndrome-d-52378https://curecurrent.com/trials/a-study-to-predict-gefitinib-s-efficacy-for-lung-cancer-by-plasma-free-nucleic-acids-egfr-gene-mutation-test-52379https://curecurrent.com/trials/sbrt-compared-with-imrt-concurrently-with-chemotherapy-in-treating-patients-with-ls-sclc-52380https://curecurrent.com/trials/hs-wbrt-for-prophylactic-cranial-irradiation-in-limited-stage-small-cell-lung-cancer-52381https://curecurrent.com/trials/the-efficacy-and-safety-of-apatinib-combined-with-etoposide-in-heavily-pretreated-advanced-non-small-cell-lung-cancer-52382https://curecurrent.com/trials/pleural-catheters-versus-thoracoscopic-pleurodesis-52383https://curecurrent.com/trials/thermal-signature-of-patients-undergoing-radiation-therapy-52384https://curecurrent.com/trials/sorafenib-and-erlotinib-or-sorafenib-alone-in-advanced-non-small-cell-lung-cancer-progressing-on-erlotinib-52385https://curecurrent.com/trials/individual-boosting-in-non-small-cell-lung-cancer-using-hypofractionation-intensity-modulated-radiation-therapy-and-resp-52386https://curecurrent.com/trials/phase-i-imaging-study-evaluating-dalotuzumab-mk0646-in-combination-with-erlotinib-for-patients-with-non-small-cell-lung-52387https://curecurrent.com/trials/safety-and-efficacy-study-of-avastin-in-locally-advanced-metastatic-or-recurrent-non-small-lung-cancer-nslc-participants-52388https://curecurrent.com/trials/two-different-dosages-of-irinotecan-combined-with-cisplatin-scheme-in-extensive-disease-small-cell-lung-cancer-52389https://curecurrent.com/trials/palliative-3-dimensional-conformal-radiation-therapy-in-reducing-radiation-side-effects-in-patients-with-lung-cancer-ico-52390https://curecurrent.com/trials/a-study-of-reolysin-in-combination-with-paclitaxel-and-carboplatin-in-patients-with-squamous-cell-carcinoma-of-the-lung-52391https://curecurrent.com/trials/impact-of-availability-of-showerpatch-for-patients-with-intravenous-catheters-52392https://curecurrent.com/trials/rad001-with-paclitaxel-and-carboplatin-in-first-line-treatment-of-patients-with-advanced-large-cell-lung-cancer-with-neu-52393https://curecurrent.com/trials/automatic-ct-to-patient-registration-during-navigated-bronchoscopy-and-ebus-52394https://curecurrent.com/trials/effect-of-regulated-pleural-pressure-on-air-leak-and-fluid-drainage-following-pulmonary-resections-a-multicenter-randomi-52395https://curecurrent.com/trials/objective-and-subjective-outcomes-of-an-electronic-chest-drainage-system-52396https://curecurrent.com/trials/counseling-and-nicotine-replacement-therapy-in-helping-adult-smokers-quit-smoking-52397https://curecurrent.com/trials/intercalated-combination-of-chemotherapy-and-tyrosine-kinase-inhibitors-as-first-line-treatment-for-patients-with-non-sm-52398https://curecurrent.com/trials/an-observational-study-of-tarceva-erlotinib-in-routine-daily-clinical-practice-as-second-line-treatment-in-patients-with-52399https://curecurrent.com/trials/hypofractionated-radiation-therapy-combined-with-concurrent-chemotherapy-for-patients-with-non-small-cell-lung-cancer-52400https://curecurrent.com/trials/high-tea-consumption-on-smoking-related-oxidative-stress-52401https://curecurrent.com/trials/study-to-evaluate-motesanib-with-or-without-carboplatin-paclitaxel-or-panitumumab-in-the-treatment-of-patients-with-adva-52402https://curecurrent.com/trials/a-study-assessing-efficacy-and-safety-of-sar125844-in-nsclc-patients-with-met-amplification-52403https://curecurrent.com/trials/outlook-quality-of-life-intervention-52404https://curecurrent.com/trials/the-correlation-between-mage-a3-prame-polymorphism-and-expression-levels-of-mage-a3-and-prame-in-nsclc-patients-52405https://curecurrent.com/trials/analysis-of-treatment-outcome-and-toxicity-in-non-small-cell-lung-cancer-patients-wither-irradiated-to-a-high-dose-for-r-52406https://curecurrent.com/trials/topotecan-in-treating-patients-with-recurrent-extensive-stage-small-cell-lung-cancer-52407https://curecurrent.com/trials/trial-of-gemcitabine-carboplatin-with-or-without-iniparib-sar240550-a-parp1-inhibitor-in-subjects-with-previously-untrea-52408https://curecurrent.com/trials/comparison-of-the-effects-of-sevoflurane-desflurane-and-total-intravenous-anaesthesia-on-pulmonary-function-tests-52409https://curecurrent.com/trials/cisplatin-etoposide-radiotherapy-consolidation-docetaxel-in-advanced-stage-iii-non-small-cell-lung-cancer-52410https://curecurrent.com/trials/a-retrospective-study-about-treatment-strategy-after-first-second-line-egfr-tki-failure-52411https://curecurrent.com/trials/phase-i-ii-study-of-fractionated-stereotactic-radiotherapy-for-early-stage-non-small-cell-lung-cancer-52412https://curecurrent.com/trials/an-observational-research-of-crizotinib-s-hepatic-toxicity-in-non-small-cell-lung-cancer-patients-52413https://curecurrent.com/trials/a-study-to-assess-the-incidence-of-egfr-mutation-in-patients-with-newly-diagnosed-locally-advanced-or-metastatic-non-sma-52414https://curecurrent.com/trials/safety-and-efficacy-of-bkm120-in-patients-with-metastatic-non-small-cell-lung-cancer-52415https://curecurrent.com/trials/tarceva-with-or-without-apatinib-in-the-advanced-lung-adenocarcinoma-52416https://curecurrent.com/trials/ixabepilone-in-combination-with-carboplatin-in-patients-with-non-small-cell-lung-cancer-52417https://curecurrent.com/trials/bevacizumab-in-extensive-small-cell-lung-cancer-52418https://curecurrent.com/trials/efficacy-study-of-avastin-with-pemetrexed-carboplatin-to-treat-elderly-patients-with-non-small-cell-lung-cancer-52419https://curecurrent.com/trials/chemoradiotherapy-of-nsclc-stage-iiib-52420https://curecurrent.com/trials/stage-i-ii-nsclc-perioperative-chemotherapy-52421https://curecurrent.com/trials/telephone-support-program-for-lung-cancer-patients-and-their-family-caregivers-52422https://curecurrent.com/trials/malignant-pleural-effusion-with-zd6474-52423https://curecurrent.com/trials/low-frequency-rotating-magnetic-system-combined-with-systemic-anti-tumor-therapy-for-advanced-lung-cancer-52424https://curecurrent.com/trials/treatment-patients-with-pulmonary-metastasis-of-liver-cancer-with-apatinib-combination-with-tace-a-clinical-study-52425https://curecurrent.com/trials/non-small-cell-lung-cancer-patients-treated-with-erlotinib-six-months-or-longer-52426https://curecurrent.com/trials/the-effect-of-aspirin-on-survival-in-lung-cancer-52427https://curecurrent.com/trials/phase-iii-study-of-the-effect-of-gtx-024-on-muscle-wasting-in-patients-with-non-small-cell-lung-cancer-nsclc-52428https://curecurrent.com/trials/clinical-study-of-bym338-for-the-treatment-of-unintentional-weight-loss-in-patients-with-cancer-of-the-lung-or-the-pancr-52429https://curecurrent.com/trials/a-study-of-auy922-in-non-small-cell-lung-cancer-patients-who-have-received-previous-two-lines-of-chemotherapy-52430https://curecurrent.com/trials/vaccine-therapy-and-gm-csf-in-treating-patients-with-acute-myeloid-leukemia-myelodysplastic-syndromes-non-small-cell-lun-52431https://curecurrent.com/trials/nov120101-poziotinib-for-1st-line-monotherapy-in-patients-with-lung-adenocarcinoma-52432https://curecurrent.com/trials/cisplatin-carboplatin-and-oxaliplatin-interactions-with-plasma-proteins-52433https://curecurrent.com/trials/phase-ii-trial-of-consolidative-thoracic-radiotherapy-for-extensive-stage-small-cell-lung-cancer-52434https://curecurrent.com/trials/metabolism-of-lipids-in-advanced-cancer-52435https://curecurrent.com/trials/hypofractionated-radiotherapy-for-small-cell-lung-cancer-52436https://curecurrent.com/trials/study-of-18f-fluorodeoxyglucose-fluglucoscan-in-patients-with-cancer-or-suspected-cancer-52437https://curecurrent.com/trials/cytogenetic-and-molecular-genetic-studies-in-bone-sarcomas-52438https://curecurrent.com/trials/study-of-18f-fluorodeoxyglucose-fluglucoscan-in-patients-receiving-a-treatment-planning-study-of-3-dimensional-conformal-52439https://curecurrent.com/trials/the-detection-of-circulating-tumor-cells-ctcs-in-patients-with-lung-cancer-undergoing-cryosurgery-combined-with-dc-cik-t-52440https://curecurrent.com/trials/apatinib-plus-docetaxel-as-2nd-line-treatment-in-patients-with-advanced-lung-adenocarcinoma-harboring-wild-type-egfr-52441https://curecurrent.com/trials/nano-drug-interventional-therapy-using-digital-subtraction-angiography-dsa-for-lung-carcinoma-52442https://curecurrent.com/trials/self-gated-breath-hold-technique-for-helical-tomotherapy-in-patients-with-non-small-cell-lung-cancer-52443https://curecurrent.com/trials/study-of-radiation-dose-intensity-concurrent-with-chemotherapy-for-limited-stage-small-cell-lung-cancer-52444https://curecurrent.com/trials/cone-beam-ct-scanning-in-lung-and-bladder-cancer-52445https://curecurrent.com/trials/safety-and-efficacy-of-dc-cik-in-patients-with-advanced-non-small-cell-lung-cancer-with-bone-metastases-52446https://curecurrent.com/trials/dc-vaccine-combined-with-cik-cells-in-patients-with-sclc-52447https://curecurrent.com/trials/clinical-value-of-sequential-gefitinib-with-pemetrexed-platinum-for-advanced-nsclc-52448https://curecurrent.com/trials/abx-combined-with-cisplatin-compared-with-gemcitabine-combined-with-cisplatin-in-nsclc-52449https://curecurrent.com/trials/the-study-of-gemcitabine-in-the-maintenance-treatment-of-advanced-non-small-cell-lung-cancer-52450https://curecurrent.com/trials/safety-and-effectiveness-study-of-chemotherapy-in-combination-with-erlotinib-or-sequential-erlotinib-for-treatment-in-pa-52451https://curecurrent.com/trials/iressa-re-challenge-in-advanced-nsclc-egfr-m-patients-who-responded-to-gefitinib-used-as-1st-line-or-previous-treatment-52452https://curecurrent.com/trials/avaperl1-study-a-study-of-avastin-bevacizumab-with-or-without-pemetrexed-as-maintenance-therapy-after-avastin-in-first-l-52453https://curecurrent.com/trials/hypofractionated-radiotherapy-for-limited-stage-small-cell-lung-cancer-52454https://curecurrent.com/trials/ts-gene-polymorphism-predicts-effect-in-patients-with-advanced-lung-cancer-52455https://curecurrent.com/trials/exploratory-study-of-qbkpn-ssi-in-non-small-cell-lung-cancer-52456https://curecurrent.com/trials/the-paco-project-a-clinical-study-of-a-patient-coach-program-in-vulnerable-lung-cancer-patients-52457https://curecurrent.com/trials/evaluation-of-post-operative-respiratory-complications-after-thoracic-surgery-in-patients-with-copd-52458https://curecurrent.com/trials/lymphangioleiomyomatosis-lam-registry-52459https://curecurrent.com/trials/sas-in-patients-with-bronchial-carcinoma-52460https://curecurrent.com/trials/early-warning-study-of-serum-thioredoixn-reductase-activity-in-excised-non-small-cell-lung-cancers-ewsotrilc-52461https://curecurrent.com/trials/correlation-research-of-thioredoxin-reductase-in-lung-cancer-52462https://curecurrent.com/trials/hypofractionated-3-dimensional-radiation-therapy-in-treating-patients-with-newly-diagnosed-stage-i-stage-ii-or-stage-iii-52463https://curecurrent.com/trials/motion-correction-of-positron-emission-tomography-pet-data-using-amplitude-gating-52464https://curecurrent.com/trials/study-of-dasatinib-in-imatinib-resistant-or-intolerant-subjects-with-chronic-or-advanced-phase-cml-or-philadelphia-chrom-52465https://curecurrent.com/trials/loading-dose-or-standard-dose-of-intravenous-ibandronate-in-treating-patients-with-lung-cancer-and-skeletal-metastasis-52466https://curecurrent.com/trials/proton-radiation-therapy-with-cisplatin-and-etoposide-followed-by-surgery-in-stage-iii-non-small-cell-lung-cancer-52467https://curecurrent.com/trials/nimotuzumab-in-combination-with-paclitaxel-liposome-and-carboplatin-tp-regimen-for-the-advanced-nsclc-patients-52468https://curecurrent.com/trials/proton-stereotactic-body-radiation-therapy-for-early-stage-non-small-cell-lung-cancer-52469https://curecurrent.com/trials/training-effects-following-resection-surgery-in-patients-with-lung-cancer-52470https://curecurrent.com/trials/quantifying-lung-tumor-movement-under-deep-inspiration-breath-holds-52471https://curecurrent.com/trials/percutaneous-cryoablation-peripheral-lung-cancer-52472https://curecurrent.com/trials/gefitinib-versus-pemetrexed-for-previously-treated-nsclc-patients-52473https://curecurrent.com/trials/understanding-symptom-recognition-and-treatment-decision-making-in-hispanic-latino-lung-cancer-patients-52474https://curecurrent.com/trials/talazoparib-in-combination-with-gemcitabine-and-cisplatin-in-patients-with-advanced-solid-tumors-52475https://curecurrent.com/trials/erlotinib-bevacizumab-for-ps-2-chemotherapy-na-ve-non-small-cell-lung-cancer-52476https://curecurrent.com/trials/battle-program-sorafenib-in-patients-with-nsclc-52477https://curecurrent.com/trials/a-phase-ii-study-of-epothilone-analog-bms-247550-in-patients-with-non-small-cell-lung-cancer-who-have-failed-first-line-52478https://curecurrent.com/trials/bay-43-9006-in-previously-untreated-patients-with-non-small-cell-lung-cancer-nsclc-52479https://curecurrent.com/trials/a-phase-ib-ii-trial-of-belotecan-and-ifosfamide-in-patients-with-extensive-disease-of-small-cell-lung-cancer-52480https://curecurrent.com/trials/effectiveness-of-electronic-health-record-based-interventions-for-improving-follow-up-in-primary-care-52481https://curecurrent.com/trials/4d-image-guided-adaptive-radiotherapy-for-lung-cancer-patient-image-acquisition-52482https://curecurrent.com/trials/assess-the-efficacy-safety-and-tolerability-of-gefitinib-iressa-250mg-as-maintenance-therapy-in-locally-advanced-or-meta-52483https://curecurrent.com/trials/prospective-study-of-active-pain-management-in-lung-cancer-outpatients-apm-52484https://curecurrent.com/trials/the-study-of-apatinib-plus-cik-as-the-third-line-therapy-for-advanced-lung-adenocarcinoma-patients-with-wild-type-egfr-52485https://curecurrent.com/trials/protocol-for-the-treatment-of-patients-with-previously-untreated-chronic-lymphocytic-leukemia-52486https://curecurrent.com/trials/clinical-trial-of-mk0683-in-combination-with-fda-approved-cancer-drugs-in-patients-with-advanced-nsclc-mk0683-058-52487https://curecurrent.com/trials/registry-for-patients-with-acquired-resistance-to-small-molecule-kinase-inhibitors-in-non-small-cell-lung-cancer-52488https://curecurrent.com/trials/vanguard-study-for-head-and-neck-cancer-or-non-small-cell-lung-cancer-nsclc-patients-52489https://curecurrent.com/trials/conventional-versus-ultrasound-guided-transbronchial-needle-aspiration-for-the-diagnosis-of-hilar-mediastinal-lymphadeno-52490https://curecurrent.com/trials/trufreeze-airway-obstruction-tao-study-52491https://curecurrent.com/trials/cytochrom-p450-3a4-and-1a2-phenotyping-for-the-individualization-of-treatment-with-sunitinib-or-erlotinib-in-cancer-pati-52492https://curecurrent.com/trials/cost-consequence-analysis-of-parenchymal-stapling-device-versus-hand-sewing-for-pulmonary-lobectomy-in-lung-disease-52493https://curecurrent.com/trials/a-study-of-tarceva-erlotinib-in-patients-with-locally-advanced-metastatic-or-recurrent-non-small-cell-cancer-who-present-52494https://curecurrent.com/trials/cellular-immunotherapy-synergize-chemotherapy-in-patients-with-stage-iv-nsclc-52495https://curecurrent.com/trials/chidamide-in-combination-with-carboplatin-and-paclitaxel-in-advanced-non-small-cell-lung-cancer-52496https://curecurrent.com/trials/a-study-of-tarceva-erlotinib-in-first-line-in-patients-with-locally-advanced-or-metastatic-lung-adenocarcinoma-with-egfr-52497https://curecurrent.com/trials/randomized-double-blind-trial-of-erlotinib-pazopanib-or-erlotinib-placebo-in-patients-with-previously-treated-advanced-n-52498https://curecurrent.com/trials/novel-detection-system-for-lung-cancer-curative-effect-monitoring-52499https://curecurrent.com/trials/study-of-camtobell-inj-belotecan-on-weekly-schedule-in-non-small-cell-lung-cancer-nsclc-patients-previously-treated-with-52500https://curecurrent.com/trials/diagnostic-value-of-ultralow-dose-computed-tomography-for-the-detection-of-pulmonary-nodules-and-lung-parenchym-alterati-52501https://curecurrent.com/trials/central-european-society-for-anticancer-research-cesar-study-of-paclitaxel-therapeutic-drug-monitoring-52502https://curecurrent.com/trials/topotecan-and-cisplatin-versus-etoposide-and-carboplatin-in-1st-line-treatment-of-patients-with-small-cell-lung-cancer-a-52503https://curecurrent.com/trials/imetelstat-as-maintenance-therapy-after-initial-induction-chemotherapy-in-non-small-cell-lung-cancer-nsclc-52504https://curecurrent.com/trials/ctp-imaging-of-lung-cancer-52505https://curecurrent.com/trials/transcutaneous-electrical-acupoint-stimulation-for-non-small-cell-lung-cancer-patients-52506https://curecurrent.com/trials/temozolomide-as-maintenance-therapy-in-small-cell-lung-cancer-52507https://curecurrent.com/trials/a-non-interventional-trial-of-erlotinib-tarceva-metastatic-non-small-cell-lung-cancer-52508https://curecurrent.com/trials/budesonide-in-treating-patients-with-lung-nodules-at-high-risk-of-developing-lung-cancer-52509https://curecurrent.com/trials/multimodality-treatment-for-patients-with-resectable-non-small-cell-lung-cancer-nsclc-beacon-study-bevacizumab-and-chemo-52510https://curecurrent.com/trials/circulating-tumor-cells-in-non-small-cell-lung-carcinoma-52511https://curecurrent.com/trials/neoadjuvant-afatinib-in-early-stage-non-small-cell-lung-cancer-52512https://curecurrent.com/trials/dasatinib-in-treating-patients-with-advanced-lung-cancer-that-is-no-longer-responding-to-erlotinib-or-gefitinib-52513https://curecurrent.com/trials/phase-ii-trial-to-correlate-radiographic-response-induced-by-gefitinib-with-mutations-in-the-protein-tyrosine-kinase-dom-52514https://curecurrent.com/trials/gefitinib-and-everolimus-in-treating-patients-with-stage-iiib-or-stage-iv-or-recurrent-non-small-cell-lung-cancer-52515https://curecurrent.com/trials/human-egfr-mutations-quantitative-detection-kit-real-time-fluorescent-pcr-method-52516https://curecurrent.com/trials/combination-paclitaxel-carboplatin-and-temozolomide-52517https://curecurrent.com/trials/an-dose-escalation-trial-of-oral-bibf-1120-in-combination-with-intravenous-vinorelbine-in-elderly-patients-with-advanced-52518https://curecurrent.com/trials/use-of-hydralazine-and-valproic-acid-in-advanced-solid-tumor-malignancies-52519https://curecurrent.com/trials/torch-a-study-of-tarceva-or-chemotherapy-for-the-treatment-of-advanced-non-small-cell-lung-cancer-52520https://curecurrent.com/trials/linsitinib-or-topotecan-hydrochloride-in-treating-patients-with-relapsed-small-cell-lung-cancer-52521https://curecurrent.com/trials/g-step-gemcitabine-based-small-cell-lung-cancer-treatment-in-elderly-patients-52522https://curecurrent.com/trials/the-distal-2-study-docetaxel-alone-or-in-combination-in-second-line-treatment-of-advanced-non-small-cell-lung-cancer-52523https://curecurrent.com/trials/a-phase-1b-2-study-of-amg-655-in-combination-with-paclitaxel-and-carboplatin-for-the-first-line-treatment-of-advanced-no-52524https://curecurrent.com/trials/comparison-of-biomarker-modulation-by-inhibition-of-egfr-and-or-src-family-52525https://curecurrent.com/trials/progression-free-survival-pfs-using-erlotinib-for-non-small-cell-lung-cancer-nsclc-in-chinese-population-52526https://curecurrent.com/trials/evaluate-the-auxiliary-diagnostic-value-of-circulating-tumor-cells-in-benign-and-malignant-lung-nodules-52527https://curecurrent.com/trials/state-of-the-art-photon-therapy-versus-particle-therapy-for-small-lung-tumors-a-planning-study-based-on-a-reference-data-52528https://curecurrent.com/trials/a-study-of-ts-1-plus-cisplatin-in-patients-with-advanced-non-small-cell-lung-cancer-52529https://curecurrent.com/trials/efficacy-and-safety-analyses-of-mirtazapine-in-nsclc-patients-with-depression-52530https://curecurrent.com/trials/egfr-mutation-detection-from-advanced-nsclc-patient-tissue-and-plasma-in-egfr-tki-treatment-52531https://curecurrent.com/trials/prevalence-of-sleep-disordered-breathing-in-patients-with-a-newly-diagnosed-non-small-cell-lung-cancer-52532https://curecurrent.com/trials/the-value-of-circulating-tumor-cells-in-patient-with-nsclc-in-postoperative-recurrence-monitoring-52533https://curecurrent.com/trials/comparative-evaluation-of-mri-and-mdct-for-the-detection-of-metastic-pulmonary-nodules-52534https://curecurrent.com/trials/immunization-with-a-pentavalent-vaccine-composed-of-klh-conjugates-of-gd2l-gd3l-globo-h-fucosyl-gm1-and-n-propionylated-52535https://curecurrent.com/trials/comparison-of-circulating-tumor-dna-and-tumor-tissue-dna-by-targeted-sequencing-in-non-small-cell-lung-cancer-52536https://curecurrent.com/trials/a-study-of-ro5083945-in-combination-with-chemotherapy-versus-chemotherapy-alone-in-patients-with-advanced-or-recurrent-n-52537https://curecurrent.com/trials/nedaplatin-docetaxel-versus-cisplatin-docetaxel-in-treatment-of-advanced-relapsed-squamous-cell-lung-cancer-52538https://curecurrent.com/trials/safety-and-efficacy-study-of-a-new-chemotherapy-agent-to-treat-small-cell-lung-cancer-52539https://curecurrent.com/trials/paclitaxel-bevacizumab-and-pemetrexed-in-patients-with-untreated-advanced-non-small-cell-lung-cancer-using-web-based-dat-52540https://curecurrent.com/trials/an-observational-study-of-erlotinib-tarceva-as-second-line-treatment-in-patients-with-locally-advanced-or-metastatic-non-52541https://curecurrent.com/trials/study-of-taxane-carboplatin-cetuximab-as-first-line-treatment-for-patients-with-advanced-metastatic-non-small-cell-lung-52542https://curecurrent.com/trials/study-of-grn163l-with-paclitaxel-and-carboplatin-in-patients-with-advanced-or-metastatic-non-small-cell-lung-cancer-52543https://curecurrent.com/trials/safety-study-of-cetuximab-in-combination-with-cisplatin-and-vinorelbine-to-treat-advanced-non-small-cell-lung-cancer-52544https://curecurrent.com/trials/the-use-of-breathing-synchronized-ct-and-pet-scans-in-radiation-therapy-treatment-planning-52545https://curecurrent.com/trials/amrubicin-cyclophosphamide-in-advanced-solid-organ-malignancies-52546https://curecurrent.com/trials/epidermal-growth-factor-receptor-egfr-status-based-gefitinib-neoadjuvant-therapy-in-non-small-cell-lung-cancer-nsclc-52547https://curecurrent.com/trials/erlotinib-concurrent-with-radiation-therapy-in-non-small-cell-lung-cancer-52548https://curecurrent.com/trials/clinical-trial-of-boanmycin-hydrochloride-with-docetaxel-for-patients-with-lung-squamous-cell-cancer-as-chemotherapy-52549https://curecurrent.com/trials/gwas-research-of-lung-cancer-in-tianjin-52550https://curecurrent.com/trials/trial-of-ombrabulin-ave8062-in-combination-with-taxane-and-platinum-in-patients-with-non-small-cell-lung-cancer-52551https://curecurrent.com/trials/a-study-of-pemetrexed-carboplatin-and-bevacizumab-in-participants-with-nonsquamous-non-small-cell-lung-cancer-52552https://curecurrent.com/trials/phase-i-study-of-weekly-topotecan-in-combination-with-sorafenib-in-treatment-of-relapsed-small-cell-lung-cancer-52553https://curecurrent.com/trials/s1-vs-pemetrexed-plus-carboplatin-in-patients-with-egfr-wild-type-stage-iiib-or-iv-nonsquamous-nsclc-52554https://curecurrent.com/trials/comparison-of-progel-sealant-to-standard-of-care-soc-for-patients-undergoing-decortication-52555https://curecurrent.com/trials/radiofrequency-ablation-of-malignant-pulmonary-nodules-52556https://curecurrent.com/trials/concurrent-nab-p-carboplatin-and-thoracic-radiotherapy-in-squamous-cell-lung-cancer-52557https://curecurrent.com/trials/a-study-of-tarceva-erlotinib-or-placebo-in-combination-with-platinum-based-therapy-as-first-line-treatment-in-patients-w-52558https://curecurrent.com/trials/a-culturally-sensitive-values-guided-aid-for-end-of-life-decision-making-52559https://curecurrent.com/trials/study-of-motesanib-amg-706-in-combination-with-paclitaxel-and-carboplatin-for-advanced-non-squamous-non-small-cell-lung-52560https://curecurrent.com/trials/pulmonary-rehabilitation-in-lymphangioleiomyomatosis-52561https://curecurrent.com/trials/pilot-study-of-model-based-iterative-reconstruction-using-64-slice-52562https://curecurrent.com/trials/safety-and-efficacy-of-aprepitant-for-cinv-in-patients-with-lung-cancer-receiving-multiple-day-cisplatin-chemotherapy-52563https://curecurrent.com/trials/afatinib-vs-erlotinib-as-2nd-tki-after-failure-to-1st-tki-and-chemotherapy-for-metastatic-nsclc-52564https://curecurrent.com/trials/patient-defined-treatment-success-and-preferences-in-stage-iv-lung-cancer-patients-52565https://curecurrent.com/trials/the-safety-and-effect-study-of-acupuncture-for-anorexia-in-patients-with-gastrointestinal-tract-and-lung-cancers-52566https://curecurrent.com/trials/study-of-enbrel-etanercept-for-the-treatment-sub-acute-pulmonary-dysfunction-after-allogeneic-stem-cell-transplant-52567https://curecurrent.com/trials/safety-study-of-recombinant-vaccinia-virus-to-treat-refractory-solid-tumors-52568https://curecurrent.com/trials/epidemiology-and-diagnosis-of-haemoptysis-a-multicenter-study-52569https://curecurrent.com/trials/dnp-modified-autologous-tumor-cell-vaccine-for-resectable-non-small-cell-lung-cancer-52570https://curecurrent.com/trials/phase-2-study-of-reolysin-in-combination-with-paclitaxel-and-carboplatin-for-non-small-cell-lung-cancer-with-kras-or-egf-52571https://curecurrent.com/trials/lung-ultrasound-in-pleuritic-chest-pain-52572https://curecurrent.com/trials/reader-study-of-deltaview-chest-radiograph-software-52573https://curecurrent.com/trials/enb-gs-tblb-for-the-diagnosis-of-ppls-52574https://curecurrent.com/trials/pulmonary-artery-sealing-using-the-harmonic-ace-shears-hs-for-vats-lobectomy-52575https://curecurrent.com/trials/pulmonary-artery-harmonic-ace-7-energy-sealing-in-open-lobectomy-52576https://curecurrent.com/trials/thoracoscopic-localization-of-pulmonary-nodules-using-direct-intracavitary-thoracoscopic-ultrasound-52577https://curecurrent.com/trials/buspirone-in-reducing-shortness-of-breath-in-patients-with-cancer-52578https://curecurrent.com/trials/a-study-of-dalteparin-prophylaxis-in-high-risk-ambulatory-cancer-patients-52579https://curecurrent.com/trials/the-need-of-fiberoptic-bronchoscopy-for-placing-an-endobronchial-blocker-52580https://curecurrent.com/trials/cancer-vaccine-study-for-unresectable-stage-iii-non-small-cell-lung-cancer-start-52581https://curecurrent.com/trials/predictive-value-of-fdg-pet-ct-dwi-and-dce-mri-scans-for-non-small-cell-lung-cancer-patients-receiving-chemotherapy-52582https://curecurrent.com/trials/a-non-interventional-study-nis-registry-for-the-epidemiological-and-scientific-evaluation-of-epidermal-growth-factor-rec-52583https://curecurrent.com/trials/feasibility-of-mutational-analysis-of-non-small-cell-lung-cancer-nsclc-using-low-volume-lung-aspirates-52584https://curecurrent.com/trials/outlook-quality-of-life-intervention-study-52585https://curecurrent.com/trials/docetaxel-taxotere-vinorelbine-and-bevacizumab-as-adjuvant-chemotherapy-for-patients-with-resected-stage-i-iii-non-small-52586https://curecurrent.com/trials/erlotinib-and-at-101-in-advanced-non-small-cell-lung-cancer-nsclc-patients-with-epidermal-growth-factor-receptor-egfr-ac-52587https://curecurrent.com/trials/cisplatin-for-malignant-pleural-effusion-in-patients-with-non-small-cell-lung-cancer-52588https://curecurrent.com/trials/ro4929097-in-treating-patients-with-advanced-non-small-cell-lung-cancer-who-have-recently-completed-treatment-with-front-52589https://curecurrent.com/trials/imaging-study-compare-4dct-image-52590https://curecurrent.com/trials/phase-2b-randomized-controlled-study-of-tecemotide-l-blp25-for-immunotherapy-of-nsclc-non-small-cell-lung-cancer-52591https://curecurrent.com/trials/erlotinib-re-challenge-for-recurrent-egfr-mutant-lung-cancer-in-patients-who-previously-received-adjuvant-erlotinib-or-g-52592https://curecurrent.com/trials/cisplatin-pemetrexed-and-imatinib-mesylate-in-malignant-mesothelioma-52593https://curecurrent.com/trials/chemotherapy-combined-with-radiation-therapy-in-treating-patients-with-limited-stage-small-cell-lung-cancer-52594https://curecurrent.com/trials/cetuximab-paclitaxel-carboplatin-and-radiation-therapy-in-treating-patients-with-unresectable-stage-iiia-or-stage-iiib-n-52595https://curecurrent.com/trials/celecoxib-and-radiation-therapy-in-treating-patients-with-locally-advanced-non-small-cell-lung-cancer-52596https://curecurrent.com/trials/gemcitabine-carboplatin-or-paclitaxel-plus-radiation-therapy-in-treating-patients-with-stage-iiia-or-iiib-non-small-cell-52597https://curecurrent.com/trials/chemotherapy-plus-radiation-therapy-with-or-without-surgery-in-treating-patients-with-stage-iiia-non-small-cell-lung-can-52598https://curecurrent.com/trials/randomized-phase-lll-study-of-imatinib-dose-optimization-vs-nilotinib-in-cml-patients-with-suboptimal-response-to-imatin-52599https://curecurrent.com/trials/role-of-bronchoscopy-in-early-lung-cancer-screening-of-high-risk-population-52600https://curecurrent.com/trials/a-study-of-erlotinib-tarceva-as-monotherapy-or-intermittent-dosing-with-docetaxel-in-patients-with-advanced-or-metastati-52601https://curecurrent.com/trials/diagnosis-of-individuals-with-pulmonary-nodules-by-different-bronchoscopy-combination-52602https://curecurrent.com/trials/prevalence-of-copd-in-our-lung-cancer-population-compared-to-controls-52603https://curecurrent.com/trials/study-of-sorafenib-maintenance-in-patients-with-ed-sclc-after-response-to-induction-chemotherapy-52604https://curecurrent.com/trials/effects-of-dexmedetomidine-on-quality-of-recovery-and-analgesia-after-video-assisted-thoracoscopic-surgery-52605https://curecurrent.com/trials/impacts-of-different-pressure-pneumoperitoneum-on-myocardial-and-pulmonary-injuries-after-robot-assisted-surgery-52606https://curecurrent.com/trials/individualized-dose-prescription-in-advanced-stage-lung-cancer-patients-using-modern-chemo-radiotherapy-52607https://curecurrent.com/trials/effects-of-palliative-care-on-quality-of-life-and-symptom-control-in-patients-with-stage-iiib-or-stage-iv-non-small-cell-52608https://curecurrent.com/trials/study-of-ganetespib-sta-9090-docetaxel-in-advanced-non-small-cell-lung-cancer-52609https://curecurrent.com/trials/radiation-therapy-cisplatin-and-etoposide-in-treating-patients-with-non-small-cell-lung-cancer-that-cannot-be-removed-by-52610https://curecurrent.com/trials/selinexor-and-docetaxel-in-treating-patients-with-recurrent-or-metastatic-squamous-cell-lung-cancer-52611https://curecurrent.com/trials/evaluation-of-flt-pet-and-dwi-mri-in-patients-with-nsclc-treated-with-a-platinum-based-doublet-as-preoperative-chemo-52612https://curecurrent.com/trials/an-observational-study-of-tarceva-erlotinib-in-elderly-patients-with-advanced-non-small-cell-lung-cancer-52613https://curecurrent.com/trials/surgery-gemcitabine-cisplatin-and-radiation-therapy-in-treating-patients-with-stage-ii-or-stage-iii-non-small-cell-lung-52614https://curecurrent.com/trials/pemetrexed-disodium-or-erlotinib-hydrochloride-as-second-line-therapy-in-treating-patients-with-advanced-non-small-cell-52615https://curecurrent.com/trials/evaluation-of-the-efficacy-of-the-combination-of-axitinib-with-pemetrexed-and-cisplatin-in-the-treatment-of-non-squamous-52616https://curecurrent.com/trials/study-of-gemcitabine-platinum-cetuximab-as-first-line-treatment-for-patients-with-advanced-metastatic-non-small-cell-lun-52617https://curecurrent.com/trials/phase-ii-study-of-anlotinib-in-patients-with-advanced-non-small-cell-lung-cancer-alter0302-52618https://curecurrent.com/trials/a-study-to-determine-whether-egfr-status-by-fish-can-predict-results-in-non-small-cell-lung-cancer-nsclc-patients-treate-52619https://curecurrent.com/trials/a-study-of-combined-c-met-inhibitor-and-pan-her-inhibitor-pf-02341066-and-pf-00299804-in-patients-with-non-small-cell-lu-52620https://curecurrent.com/trials/a-phase-i-study-of-cetuximab-in-combination-with-gefitinib-in-patients-with-advanced-metastatic-non-small-cell-lung-canc-52621https://curecurrent.com/trials/erlotinib-is-being-studied-with-or-without-an-investigational-drug-pf-02341066-in-patients-with-lung-cancer-52622https://curecurrent.com/trials/an-exploratory-pharmacogenomic-study-of-monotherapy-erbitux-in-subjects-with-metastatic-non-small-cell-lung-carcinoma-52623https://curecurrent.com/trials/a-study-of-tremelimumab-combined-with-the-anti-pd-l1-medi4736-antibody-in-malignant-mesothelioma-nibit-meso-1-52624https://curecurrent.com/trials/s0424-carcinogens-in-lung-tissue-from-smokers-closed-to-entry-as-of-7-15-07-and-non-smokers-with-newly-diagnosed-stage-i-52625https://curecurrent.com/trials/study-of-stereotactic-ablative-radiotherapy-sabr-in-elderly-stage-i-nsclc-52626https://curecurrent.com/trials/multidisciplinary-rehabilitation-after-cancer-pulmonis-operation-52627https://curecurrent.com/trials/a-clinical-study-conducted-in-multiple-centers-comparing-veliparib-in-combination-with-carboplatin-and-paclitaxel-versus-52628https://curecurrent.com/trials/computed-tomography-ct-perfusion-imaging-of-lung-cancer-52629https://curecurrent.com/trials/study-of-tecemotide-l-blp25-in-participants-with-stage-iii-unresectable-non-small-cell-lung-cancer-nsclc-following-prima-52630https://curecurrent.com/trials/a-phase-i-ii-study-of-paclitaxel-carboplatin-and-ym155-survivin-suppressor-in-subjects-with-solid-tumors-phase-i-and-adv-52631https://curecurrent.com/trials/a-study-of-pertuzumab-with-erlotinib-in-patients-with-locally-advanced-or-metastatic-non-small-cell-lung-cancer-nsclc-52632https://curecurrent.com/trials/vaccine-therapy-in-treating-patients-with-liver-or-lung-metastases-from-colorectal-cancer-52633https://curecurrent.com/trials/prophylactic-cranial-irradiation-pci-cognitive-tests-in-non-small-cell-lung-cancer-nsclc-patients-52634https://curecurrent.com/trials/ph-ii-of-a-novel-anti-angiogenic-agent-in-combination-with-chemotherapy-for-the-treatment-of-non-small-cell-lung-cancer-52635https://curecurrent.com/trials/comparing-diagnostic-yield-between-r-ebus-guided-cryo-biopsy-vs-ct-guided-biopsy-for-ppl-52636https://curecurrent.com/trials/a-comparison-between-bms-690514-and-erlotinib-in-patients-who-were-previously-treated-for-nsclc-52637https://curecurrent.com/trials/pemetrexed-or-docetaxel-with-or-without-erlotinib-in-stage-iiib-or-stage-iv-non-small-cell-lung-cancer-52638https://curecurrent.com/trials/trial-of-bms-690514-in-non-small-cell-lung-cancer-subjects-who-have-been-treated-with-gefitinib-or-erlotinib-and-are-gen-52639https://curecurrent.com/trials/identifying-early-lung-cancer-cells-in-malignant-pleural-effusion-samples-from-patients-with-primary-lung-cancer-52640https://curecurrent.com/trials/disease-management-program-or-usual-care-in-patients-with-stage-iii-or-stage-iv-lung-cancer-pancreatic-cancer-ovarian-ca-52641https://curecurrent.com/trials/phase-ii-study-of-brivanib-bms-582664-to-treat-multiple-tumor-types-52642https://curecurrent.com/trials/cetuximab-plus-conformal-thoracic-radiotherapy-in-patients-pts-with-inoperable-or-unresectable-locally-advanced-non-smal-52643https://curecurrent.com/trials/pazopanib-in-relapsed-and-refractory-small-cell-lung-cancer-52644https://curecurrent.com/trials/a-study-of-avastin-bevacizumab-in-combination-with-gemcitabine-with-or-without-cisplatin-in-first-line-treatment-of-elde-52645https://curecurrent.com/trials/neoadjuvant-chemoradiotherapy-with-or-without-gefitinib-in-treating-patients-with-stage-iiia-or-stage-iiib-non-small-cel-52646https://curecurrent.com/trials/enzastaurin-carboplatin-and-gemcitabine-with-or-without-bevacizumab-in-treating-patients-with-recurrent-stage-iiib-or-st-52647https://curecurrent.com/trials/metronomic-docetaxel-and-bevacizumab-in-patients-with-small-cell-lung-cancer-52648https://curecurrent.com/trials/trial-of-continuous-once-daily-oral-treatment-using-bibw-2992-afatinib-plus-sirolimus-rapamune-in-patients-with-non-smal-52649https://curecurrent.com/trials/a-randomized-trial-of-pf-00299804-taken-orally-versus-erlotinib-taken-orally-for-treatment-of-advanced-non-small-cell-lu-52650https://curecurrent.com/trials/strategy-of-surgical-resection-with-adjuvant-therapy-for-iiia-nsclc-and-n2-disease-only-in-subaortic-or-paraaortic-level-52651https://curecurrent.com/trials/trebananib-and-temsirolimus-in-treating-patients-with-solid-tumors-that-are-metastatic-or-cannot-be-removed-by-surgery-52652https://curecurrent.com/trials/erlotinib-hydrochloride-in-treating-non-small-cell-lung-cancer-that-is-metastatic-or-cannot-be-removed-by-surgery-in-pat-52653https://curecurrent.com/trials/surveillance-for-new-lung-primaries-52654https://curecurrent.com/trials/trial-of-bibw-2992-afatinib-cetuximab-in-non-small-cell-lung-cancer-52655https://curecurrent.com/trials/optical-coherence-tomography-of-the-airway-for-lung-cancer-or-lung-disease-52656https://curecurrent.com/trials/a-phase-1-study-of-imgn289-in-adult-patients-with-egfr-positive-solid-tumors-52657https://curecurrent.com/trials/celecoxib-in-treating-patients-with-stage-iiib-or-stage-iv-non-small-cell-lung-cancer-52658https://curecurrent.com/trials/trial-of-zd6474-and-faslodex-in-non-small-cell-lung-cancer-52659https://curecurrent.com/trials/erlotinib-hydrochloride-and-cetuximab-in-treating-patients-with-advanced-gastrointestinal-cancer-head-and-neck-cancer-no-52660https://curecurrent.com/trials/pioglitazone-to-treat-adults-undergoing-surgery-for-non-small-cell-lung-cancer-52661https://curecurrent.com/trials/a-broad-multi-histology-phase-ii-study-of-the-multi-kinase-inhibitor-r935788-fostamatinib-disodium-in-advanced-colorecta-52662https://curecurrent.com/trials/time-trends-in-waiting-times-of-nsclc-patients-52663https://curecurrent.com/trials/ro4929097-and-erlotinib-hydrochloride-in-treating-patients-with-stage-iv-or-recurrent-non-small-cell-lung-cancer-52664https://curecurrent.com/trials/cabazitaxel-in-relapsed-and-metastatic-nsclc-52665https://curecurrent.com/trials/docetaxel-plus-bevacizumab-for-elderly-patients-with-stage-iv-nsclc-52666https://curecurrent.com/trials/combination-of-erlotinib-and-bevacizumab-as-second-line-treatment-in-patients-with-non-small-cell-lung-cancer-52667https://curecurrent.com/trials/bortezomib-in-combination-with-gemcitabine-and-cisplatin-in-advanced-or-metastatic-non-small-cell-lung-cancer-52668https://curecurrent.com/trials/bevacizumab-avastin-erlotinib-as-first-line-therapy-for-stage-iiib-iv-or-recurrent-non-squamous-cell-lung-cancer-52669https://curecurrent.com/trials/dna-chip-based-prognosis-of-lung-cancer-52670https://curecurrent.com/trials/mtd-determination-safety-and-efficacy-of-the-decitabine-genistein-drug-combination-in-advanced-solid-tumors-and-non-smal-52671https://curecurrent.com/trials/intrapleural-gene-transfer-for-pleural-mesothelioma-52672https://curecurrent.com/trials/prone-patient-positioning-in-reducing-tumor-motion-and-improving-breathing-reproduction-in-patients-with-lung-cancer-und-52673https://curecurrent.com/trials/a-study-of-erlotinib-tarceva-after-surgery-with-or-without-adjuvant-chemotherapy-in-non-small-cell-lung-carcinoma-nsclc-52674https://curecurrent.com/trials/stereotactic-radiosurgery-followed-by-wedge-resection-in-treating-patients-with-early-stage-peripheral-non-small-cell-lu-52675https://curecurrent.com/trials/metabolic-changes-in-patients-with-chronic-cardiopulmonary-disease-52676https://curecurrent.com/trials/nimotuzumab-in-combination-with-radiochemotherapy-for-patients-with-stage-iiia-iiib-non-small-cell-lung-cancer-52677https://curecurrent.com/trials/s0536-cetuximab-paclitaxel-carboplatin-and-bevacizumab-in-treating-patients-with-advanced-non-small-cell-lung-cancer-52678https://curecurrent.com/trials/mindfulness-for-lung-cancer-patients-and-partners-52679https://curecurrent.com/trials/endobronchial-ultrasound-elastography-the-utility-of-strain-ratio-for-lymph-node-staging-in-lung-cancer-patients-52680https://curecurrent.com/trials/safety-and-efficacy-of-mix-vaccine-in-lung-carcinoma-patient-52681https://curecurrent.com/trials/pulmonary-vasculopathy-under-second-line-therapy-of-chronic-myeloid-leukemia-52682https://curecurrent.com/trials/icotinib-in-combination-with-chemotherapy-versus-chemotherapy-alone-in-patients-progressed-after-icotinib-treatment-52683https://curecurrent.com/trials/first-line-treatment-with-icotinib-in-elder-nsclc-egfr-mutated-patients-52684https://curecurrent.com/trials/are-doctors-familiar-with-the-test-characteristics-of-lung-cancer-screening-52685https://curecurrent.com/trials/monet1-motesanib-nsclc-efficacy-and-tolerability-study-52686https://curecurrent.com/trials/study-of-use-of-paravertebral-blocks-for-pain-relief-in-video-assisted-lung-surgery-52687https://curecurrent.com/trials/trial-of-bevacizumab-and-ixabepilone-for-advanced-or-metastatic-non-small-cell-lung-cancer-nsclc-52688https://curecurrent.com/trials/study-of-apatinib-in-ret-fusion-positive-advanced-non-small-cell-lung-cancer-52689https://curecurrent.com/trials/a-study-to-diagnose-lung-cancer-by-sputum-cytology-01-312-52690https://curecurrent.com/trials/eus-b-fna-vs-eus-fna-for-left-adrenal-gland-analysis-in-lung-cancer-patients-52691https://curecurrent.com/trials/a-study-of-ranpirnase-onconase-to-pemetrexed-plus-carboplatin-in-patients-with-non-squamous-non-small-cell-lung-cancer-52692https://curecurrent.com/trials/a-open-label-prospective-cohort-trial-of-curcumin-plus-tyrosine-kinase-inhibitors-tki-for-egfr-mutant-advanced-nsclc-52693https://curecurrent.com/trials/effectiveness-of-additional-acupuncture-therapy-for-lung-cancer-patients-52694https://curecurrent.com/trials/efficacy-and-safety-of-pyrotinib-in-patients-with-her2-mutation-advanced-non-small-cell-lung-cancer-52695https://curecurrent.com/trials/nimotuzumab-plus-docetaxel-in-chemotherapy-refractory-resistant-patients-with-advanced-non-small-cell-lung-cancer-52696https://curecurrent.com/trials/the-quality-of-life-assessment-of-lung-cancer-patients-in-china-52697https://curecurrent.com/trials/study-of-lonafarnib-in-combination-with-paclitaxel-and-carboplatin-in-patients-with-non-small-cell-lung-cancer-study-p01-52698https://curecurrent.com/trials/ultra-violet-fluorescence-bronchial-cancer-location-52699https://curecurrent.com/trials/pulsed-paclitaxel-and-daily-thoracic-radiotherapy-for-inoperable-stage-i-ii-or-unresectable-lung-cancer-52700https://curecurrent.com/trials/resistance-training-in-lung-cancer-patients-on-chemotherapy-52701https://curecurrent.com/trials/expression-and-sequence-of-calcium-channels-in-non-small-cell-lung-carcinoma-nsclc-52702https://curecurrent.com/trials/a-study-of-tarceva-erlotinib-to-compare-two-different-doses-in-in-currently-smoking-patients-with-advanced-or-metastatic-52703https://curecurrent.com/trials/nimotuzumab-in-combination-with-cisplatin-and-docetaxel-for-patients-with-advanced-non-small-cell-lung-cancer-52704https://curecurrent.com/trials/arq-197-plus-erlotinib-in-patient-with-locally-advanced-or-metastatic-egfr-mutation-positive-non-small-cell-lung-cancer-52705https://curecurrent.com/trials/safety-study-of-tecemotide-l-blp25-in-non-small-cell-lung-cancer-nsclc-subjects-with-unresectable-stage-iii-disease-52706https://curecurrent.com/trials/ido-peptid-vaccination-for-stage-iii-iv-non-small-cell-lung-cancer-patients-52707https://curecurrent.com/trials/feasibility-study-of-pemetrexed-in-combination-with-cisplatin-or-carboplatin-as-adjuvant-treatment-of-non-small-cell-lun-52708https://curecurrent.com/trials/belotaxel-docetaxel-and-belloxa-oxaliplatin-in-advanced-nsclc-52709https://curecurrent.com/trials/erlotinib-and-standard-platinum-based-chemotherapy-for-newly-diagnosed-advanced-non-small-cell-carcinoma-of-the-lung-52710https://curecurrent.com/trials/phase-ii-study-of-s-488410-to-treat-non-small-cell-lung-cancer-52711https://curecurrent.com/trials/a-long-term-study-to-evaluate-the-safety-tolerability-and-efficacy-of-cp-690-550-in-patients-with-moderate-to-severe-pla-52712https://curecurrent.com/trials/low-dose-computed-tomography-screening-for-lung-cancer-in-relatives-with-family-history-of-lung-cancer-52713https://curecurrent.com/trials/pemetrexed-combined-with-synchronous-gefitinib-as-adjuvent-therapy-in-patient-with-egfr-mutant-lung-adenocarcinoma-52714https://curecurrent.com/trials/response-evaluation-in-malignant-pleural-mesothelioma-52715https://curecurrent.com/trials/survey-on-chinese-medicine-syndrome-for-patients-with-non-small-cell-lung-cancer-52716https://curecurrent.com/trials/endostar-treatment-of-advanced-non-small-cell-lung-cancer-multi-center-clinical-research-52717https://curecurrent.com/trials/circulating-fibrocytes-in-non-small-cell-lung-cancer-52718https://curecurrent.com/trials/tauras-t790-aura-screenfailure-soc-registry-study-52719https://curecurrent.com/trials/circulating-tumor-cells-in-lung-cancer-52720https://curecurrent.com/trials/tumor-associated-macrophage-in-advanced-non-small-cell-lung-cancer-52721https://curecurrent.com/trials/role-of-a-silicone-prosthesis-to-prevent-airway-obstruction-recurrence-in-lung-cancers-52722https://curecurrent.com/trials/influence-of-prior-chemotherapy-on-clinical-benefit-with-erlotinib-in-patients-with-advanced-non-squamous-non-small-cell-52723https://curecurrent.com/trials/a-study-of-tarceva-erlotinib-in-elderly-patients-with-advanced-non-small-cell-lung-cancer-52724https://curecurrent.com/trials/assessment-of-video-assisted-thoracoscopic-surgery-vats-versus-open-surgery-for-patients-undergoing-lobectomy-52725https://curecurrent.com/trials/a-phase-iia-study-of-mk0457-in-patients-with-cancer-of-the-lung-0457-006-52726https://curecurrent.com/trials/combination-chemotherapy-and-imatinib-mesylate-in-treating-patients-with-extensive-stage-small-cell-lung-cancer-52727https://curecurrent.com/trials/cryospray-ablation-tm-in-malignant-airway-disease-to-determine-safety-and-tissue-effect-in-the-lung-ice-the-mad-52728https://curecurrent.com/trials/antinociceptive-modalities-on-ischemia-reperfusion-injury-52729https://curecurrent.com/trials/a-randomized-trial-to-study-the-safety-and-efficacy-of-egf-cancer-vaccination-in-late-stage-iiib-iv-non-small-cell-lung-52730https://curecurrent.com/trials/pemetrexed-and-lbh589-in-patients-with-advanced-non-small-cell-lung-cancer-52731https://curecurrent.com/trials/efficacy-of-nebulized-pulmicort-respules-in-primary-lung-cancer-patients-with-copd-52732https://curecurrent.com/trials/improving-management-of-breathlessness-in-patients-with-lung-cancer-52733https://curecurrent.com/trials/the-prevalence-of-lung-cancer-in-patients-with-interstitial-lung-disease-52734https://curecurrent.com/trials/monosialoganglioside-preventing-neurotoxicity-induced-by-albumin-bound-paclitaxel-chemotherapy-in-lung-cancer-patients-52735https://curecurrent.com/trials/safety-efficacy-and-side-effects-study-of-interventional-cryotherapy-in-the-pleural-space-ice-pls-52736https://curecurrent.com/trials/neoadjuvant-therapy-of-icotinib-in-epidermal-growth-factor-receptor-mutated-nsclc-patients-52737https://curecurrent.com/trials/icotinib-in-advanced-non-small-cell-lung-cancer-nsclc-with-hepatic-insufficiency-52738https://curecurrent.com/trials/icotinib-with-whole-brain-radiation-therapy-in-nsclc-patients-with-brain-metastases-52739https://curecurrent.com/trials/feasibility-of-magnetic-resonance-spectroscopy-in-lung-cancer-52740https://curecurrent.com/trials/sputum-labeling-utilizing-synthetic-meso-tetra-4-carboxyphenyl-porphine-tcpp-for-detection-of-lung-cancer-52741https://curecurrent.com/trials/recombinant-human-endostatin-combined-with-np-in-neoadjuvant-chemotherapy-of-stage-a-nsclc-52742https://curecurrent.com/trials/taxotere-plus-cisplatin-versus-alimta-plus-cisplatin-in-1st-line-non-squamous-cell-type-lung-cancer-52743https://curecurrent.com/trials/four-versus-six-cycles-of-pemetrexed-platinum-for-mpm-52744https://curecurrent.com/trials/pemetrexed-disodium-and-carboplatin-or-cisplatin-with-or-without-erlotinib-hydrochloride-in-treating-patient-with-stage-52745https://curecurrent.com/trials/biofeedback-training-in-patients-with-advanced-lung-cancer-a-pilot-study-52746https://curecurrent.com/trials/a-study-of-alimta-cisplatin-gefitinib-for-asian-non-smoking-participants-with-non-small-cell-lung-cancer-52747https://curecurrent.com/trials/t790m-mutation-positive-2nd-line-standard-of-care-registry-52748https://curecurrent.com/trials/safety-and-effect-of-pertuzumab-in-patients-with-advanced-non-small-cell-lung-cancer-which-has-progressed-after-prior-ch-52749https://curecurrent.com/trials/screening-for-occult-malignancy-in-patients-with-idiopathic-venous-thromboembolism-52750https://curecurrent.com/trials/ultrathin-bronchoscopy-for-solitary-pulmonary-nodules-52751https://curecurrent.com/trials/study-of-gleevec-and-weekly-paclitaxel-in-patients-aged-70-or-older-with-advanced-non-small-cell-lung-cancer-52752https://curecurrent.com/trials/erlotinib-100mg-qd-versus-gefitinib-250mg-qd-for-egfr-mutant-nsclc-52753https://curecurrent.com/trials/effects-of-nonintubated-versus-intubated-general-anesthesia-on-recovery-after-thoracoscopic-lung-resection-52754https://curecurrent.com/trials/a-clinical-trial-of-vorinostat-mk0683-saha-in-combination-with-fda-approved-cancer-drugs-in-patients-with-advanced-non-s-52755https://curecurrent.com/trials/evaluate-erlotinib-efficacy-and-safety-as-the-2nd-3rd-treatment-in-nsclc-with-egfr-m-and-c-met-52756https://curecurrent.com/trials/icotinib-in-advanced-metastatic-patients-with-nsclc-previously-treated-with-chemotherapy-52757https://curecurrent.com/trials/a-phase-ii-study-of-mgcd0103-mg-0103-in-patients-with-refractory-chronic-lymphocytic-leukemia-52758https://curecurrent.com/trials/study-of-default-options-in-advance-directives-52759https://curecurrent.com/trials/diffusion-weighted-magnetic-resonance-imaging-for-the-characterization-of-solitary-pulmonary-lesions-52760https://curecurrent.com/trials/nutrition-and-physical-exercise-study-52761https://curecurrent.com/trials/cryospray-ablation-tm-thoracic-patient-registry-52762https://curecurrent.com/trials/68ga-alfatideii-for-the-differential-diagnosis-of-of-lung-cancer-and-lung-tuberculosis-by-pet-ct-52763https://curecurrent.com/trials/comparison-of-lobectomy-and-segmentectomy-for-ct1an0m0-peripheral-nsclc-52764https://curecurrent.com/trials/a-safety-and-efficacy-trial-of-amplimexon-plus-taxotere-in-metastatic-non-small-cell-lung-cancer-52765https://curecurrent.com/trials/coagulation-profile-in-patients-undergoing-video-assisted-thorascopic-surgery-vats-for-lung-cancer-52766https://curecurrent.com/trials/the-effect-and-mechanism-of-electroacupuncture-on-acute-chemotherapy-induced-nausea-and-vomiting-52767https://curecurrent.com/trials/powered-echelon-device-in-vats-surgery-52768https://curecurrent.com/trials/a-study-of-induction-and-maintenance-treatment-of-advanced-or-metastatic-non-squamous-non-small-cell-lung-cancer-52769https://curecurrent.com/trials/bronchoscopic-intratumoral-chemotherapy-for-small-cell-lung-cancer-sclc-52770https://curecurrent.com/trials/isolated-thoracic-perfusion-itp-f-for-mpm-52771https://curecurrent.com/trials/phase-i-trial-of-docetaxel-and-low-dose-fractionated-radiation-in-the-treatment-of-metastatic-or-recurrent-nsclc-52772https://curecurrent.com/trials/efficacy-study-of-additional-chemotherapy-after-concurrent-chemoradiation-in-non-small-cell-lung-cancer-52773https://curecurrent.com/trials/continuing-evaluation-of-the-lungpoint-atv-system-52774https://curecurrent.com/trials/carboplatin-docetaxel-bevacizumab-and-erlotinib-versus-chemotherapy-alone-in-resected-nsclc-52775https://curecurrent.com/trials/sublingual-anvirzel-in-advance-non-small-cell-lung-cancer-nsclc-52776https://curecurrent.com/trials/a-study-of-ly2875358-in-japanese-participants-with-advanced-cancer-52777https://curecurrent.com/trials/airway-epithelium-gene-expression-aegis-ide-52778https://curecurrent.com/trials/hair-sparing-whole-brain-radiotherapy-52779https://curecurrent.com/trials/stereotactic-boost-for-locally-advanced-non-small-cell-lung-cancer-52780https://curecurrent.com/trials/vaccine-therapy-in-treating-lung-cancer-patients-with-cancer-stem-cells-52781https://curecurrent.com/trials/a-study-of-tarceva-erlotinib-in-patients-with-locally-advanced-or-metastatic-non-small-cell-lung-cancer-who-present-egfr-52782https://curecurrent.com/trials/study-of-docetaxel-gemcitabine-followed-by-chemo-radiotherapy-chemo-rt-with-or-without-consolidation-chemotherapy-in-iii-52783https://curecurrent.com/trials/non-small-cell-lung-cancer-and-quality-of-life-52784https://curecurrent.com/trials/risk-stratification-of-patients-using-the-lung-cancer-biomarker-panel-in-china-52785https://curecurrent.com/trials/health-related-quality-of-life-after-video-assisted-thoracoscopic-lobectomy-for-lung-cancer-52786https://curecurrent.com/trials/study-of-a-tiotropium-inhaler-for-shortness-of-breath-in-advanced-non-small-cell-lung-cancer-52787https://curecurrent.com/trials/increased-dose-of-icotinib-in-advanced-none-small-cell-lung-cancer-patients-after-routine-gefitinib-therapy-52788https://curecurrent.com/trials/icotinib-as-adjuvant-therapy-in-treating-non-small-cell-lung-cancer-patients-with-positive-egfr-mutation-52789https://curecurrent.com/trials/high-dose-versus-routine-dose-icotinib-in-advanced-non-small-cell-lung-cancer-patients-with-stable-disease-52790https://curecurrent.com/trials/evaluation-of-non-cytotoxic-suramin-as-a-chemosensitizer-in-non-small-cell-lung-cancer-52791https://curecurrent.com/trials/a-study-of-ganetespib-in-subjects-with-alk-positive-non-small-cell-lung-cancer-nsclc-52792https://curecurrent.com/trials/epidemiological-study-to-describe-non-small-cell-lung-cancer-nsclc-clinical-management-patterns-in-central-eastern-europ-52793https://curecurrent.com/trials/study-of-advanced-bulky-malignancies-with-spatially-fractioned-radiation-therapy-52794https://curecurrent.com/trials/indiaclen-multicentre-trial-of-home-versus-hospital-oral-amoxicillin-for-management-of-severe-pneumonia-in-children-52795https://curecurrent.com/trials/trial-of-poor-performance-status-patients-topps-52796https://curecurrent.com/trials/carboplatin-plus-gemcitabine-for-elderly-patients-with-stage-iv-nsclc-52797https://curecurrent.com/trials/correlation-of-x-ray-and-pathology-with-needle-biopsy-of-lung-tumors-52798https://curecurrent.com/trials/everolimus-rad001-for-the-treatment-of-malignant-pleural-mesothelioma-with-merlin-nf2-loss-as-a-biomarker-to-predict-sen-52799https://curecurrent.com/trials/phase-ii-docetaxel-carboplatin-xrt-surgical-resection-in-stage-iii-nsclc-52800https://curecurrent.com/trials/phase-iii-lucanix-vaccine-therapy-in-advanced-non-small-cell-lung-cancer-nsclc-following-front-line-chemotherapy-52801https://curecurrent.com/trials/tarceva-and-at-101-for-patients-with-advanced-non-small-cell-lung-cancer-52802https://curecurrent.com/trials/the-prognostic-and-predictive-value-of-the-ca-125-marker-in-lung-cancer-monitoring-52803https://curecurrent.com/trials/first-line-treatment-of-subjects-with-extensive-disease-small-cell-lung-cancer-with-weekly-hycamtin-and-paraplatin-52804https://curecurrent.com/trials/dose-escalation-study-of-th-302-in-combination-with-a-gemcitabine-or-b-docetaxel-or-c-pemetrexed-to-treat-advanced-solid-52805https://curecurrent.com/trials/perioperative-rehabilitation-in-operation-for-lung-cancer-52806https://curecurrent.com/trials/comparative-study-of-chemoradiation-and-sequential-chemoradiation-about-lung-adenocarcinoma-patients-with-postoperative-52807https://curecurrent.com/trials/lung-screening-study-52808https://curecurrent.com/trials/dasatinib-in-treating-patients-with-relapsed-small-cell-lung-cancer-52809https://curecurrent.com/trials/obatoclax-mesylate-and-topotecan-hydrochloride-in-treating-patients-with-relapsed-or-refractory-small-cell-lung-cancer-o-52810https://curecurrent.com/trials/a-study-to-evaluate-the-safety-and-efficacy-of-zoledronic-acid-in-the-prevention-or-delaying-of-bone-metastasis-in-patie-52811https://curecurrent.com/trials/pm-01-imprime-pgg-with-bth1704-and-gemcitabine-for-advanced-pancreatic-cancer-52812https://curecurrent.com/trials/ef5-in-assessing-tumor-response-to-anticancer-therapy-in-patients-with-stage-i-stage-ii-or-stage-iii-non-small-cell-lung-52813https://curecurrent.com/trials/immunotoxin-therapy-in-treating-patients-with-advanced-cancer-52814https://curecurrent.com/trials/e7080-in-combination-with-carboplatin-and-paclitaxel-in-patients-with-non-small-cell-lung-cancer-nsclc-52815https://curecurrent.com/trials/cetuximab-in-patients-with-lung-adenocarcinoma-receiving-erlotinib-that-have-developed-acquired-resistance-to-erlotinib-52816https://curecurrent.com/trials/immunotoxin-therapy-in-treating-patients-with-advanced-solid-tumors-52817https://curecurrent.com/trials/chemotherapy-of-nsclc-with-or-without-icotinib-52818https://curecurrent.com/trials/profile-of-soluble-and-cellular-biomarkers-and-of-functional-imaging-during-antiangiogenic-therapies-in-cancer-patients-52819https://curecurrent.com/trials/fluorescent-light-bronchoscopy-plus-white-light-bronchoscopy-for-early-detection-of-lung-cancer-52820https://curecurrent.com/trials/decitabine-in-treating-patients-with-unresectable-lung-or-esophageal-cancer-or-malignant-mesothelioma-of-the-pleura-52821https://curecurrent.com/trials/paclitaxel-and-hyperthermic-perfusion-in-treating-patients-with-lung-cancer-or-lung-metastases-that-cannot-be-removed-by-52822https://curecurrent.com/trials/sequential-icotinib-plus-chemotherapy-versus-icotinib-alone-as-first-line-treatment-in-stage-iiib-iv-lung-adenocarcinoma-52823https://curecurrent.com/trials/study-using-wst11-in-patients-with-obstructing-endobronchial-non-small-cell-lung-cancer-52824https://curecurrent.com/trials/bevacizumab-cisplatin-etoposide-and-radiation-therapy-in-treating-patients-with-limited-stage-small-cell-lung-cancer-52825https://curecurrent.com/trials/abraxane-and-rt-for-non-small-cell-lung-cancer-nsclc-52826https://curecurrent.com/trials/acetyl-l-carnitine-in-combination-with-a-cisplatin-containing-chemotherapy-as-first-line-treatment-of-advanced-or-metast-52827https://curecurrent.com/trials/prognostic-and-dynamic-change-of-ctc-enumeration-in-advanced-nsclc-with-chemotherapy-and-targeted-therapy-52828https://curecurrent.com/trials/a-phase-iii-randomized-double-blind-placebo-controlled-trial-comparing-the-efficacy-of-gemcitabine-cisplatin-and-sorafen-52829https://curecurrent.com/trials/quality-of-life-and-pain-outcomes-following-video-assisted-thoracic-surgery-vats-anatomic-lung-resection-versus-thoracot-52830https://curecurrent.com/trials/benefits-of-tobacco-free-cigarette-52831https://curecurrent.com/trials/study-of-polyphenon-e-in-addition-to-erlotinib-in-advanced-non-small-cell-lung-cancer-52832https://curecurrent.com/trials/a-study-of-carboplatin-paclitaxel-and-mk0683-in-patients-with-chemotherapy-naive-non-small-cell-lung-cancer-nsclc-0683-0-52833https://curecurrent.com/trials/a-study-of-iv-casopitant-for-the-prevention-of-nausea-and-vomiting-caused-by-cisplatin-based-highly-emetogenic-chemother-52834https://curecurrent.com/trials/echocardiographic-evaluation-of-the-change-on-pulmonary-blood-flow-and-cardiac-function-induced-by-capnothorax-during-on-52835https://curecurrent.com/trials/safety-study-of-cord-blood-derived-cytokine-induced-killer-cells-in-patients-with-solid-tumor-after-radical-resection-52836https://curecurrent.com/trials/regulatory-hycamtin-oral-pms-52837https://curecurrent.com/trials/imatinib-mesylate-in-treating-patients-with-relapsed-or-refractory-solid-tumors-of-childhood-52838https://curecurrent.com/trials/does-moderate-intensity-exercise-help-prevent-smoking-relapse-among-women-52839https://curecurrent.com/trials/ef5-in-measuring-tumor-hypoxia-in-patients-with-stage-i-iii-non-small-cell-lung-cancer-52840https://curecurrent.com/trials/cabazitaxel-compared-to-topotecan-for-the-treatment-of-small-cell-lung-cancer-52841https://curecurrent.com/trials/prophylactic-cranial-irradiation-pci-vs-observation-in-stage-iii-nsclc-52842https://curecurrent.com/trials/safety-tolerability-and-pharmacokinetics-of-multiple-ascending-doses-of-simotinib-hydrochloride-in-patients-with-advance-52843https://curecurrent.com/trials/a-clinical-study-on-the-safety-and-efficacy-of-debio-0932-in-combination-with-standard-of-care-in-patients-with-non-smal-52844https://curecurrent.com/trials/a-phase-1b-2-study-in-asian-subjects-with-non-small-cell-lung-cancer-52845https://curecurrent.com/trials/study-assessing-fosaprepitant-in-advanced-nsclc-patients-treated-with-carboplatin-based-chemotherapy-52846https://curecurrent.com/trials/oxidative-damage-and-antioxidant-mechanisms-in-copd-52847https://curecurrent.com/trials/zileuton-with-or-without-celecoxib-as-chemopreventive-agents-in-smokers-52848https://curecurrent.com/trials/icotinib-with-concurrent-radiotherapy-vs-chemoradiotherapy-in-non-small-cell-lung-cancer-52849https://curecurrent.com/trials/a-study-of-tarceva-erlotinib-in-sequential-combination-with-gemcitabine-as-first-line-therapy-in-patients-with-advanced-52850https://curecurrent.com/trials/intervention-to-improve-continuity-of-care-in-lung-cancer-patients-52851https://curecurrent.com/trials/a-study-of-tarceva-erlotinib-in-patients-with-locally-advanced-or-metastatic-non-small-cell-lung-cancer-following-4-cycl-52852https://curecurrent.com/trials/randomized-trial-of-gemcitabine-cisplatin-pf-3512676-vs-gemcitabine-cisplatin-alone-in-patients-with-advanced-nsclc-52853https://curecurrent.com/trials/tarceva-icorg-08-41-52854https://curecurrent.com/trials/inhaled-sargramostim-in-treating-patients-with-first-pulmonary-lung-recurrence-of-osteosarcoma-52855https://curecurrent.com/trials/trial-of-paclitaxel-carboplatin-pf-3512676-vs-paclitaxel-carboplatin-alone-in-patients-with-advanced-non-small-cell-lung-52856https://curecurrent.com/trials/radiation-therapy-plus-chemotherapy-in-treating-patients-with-non-small-cell-lung-cancer-52857https://curecurrent.com/trials/clinical-trial-of-erlotinib-and-pemetrexed-for-maintenance-treatment-in-lung-adenocarcinoma-52858https://curecurrent.com/trials/bb-10901-in-treating-patients-with-relapsed-or-refractory-solid-tumors-52859https://curecurrent.com/trials/intrapleural-bevacizumab-and-cisplatin-therapy-for-malignant-pleural-effusion-caused-by-non-small-cell-lung-cancer-52860https://curecurrent.com/trials/etanercept-for-non-infectious-lung-injury-following-bone-marrow-transplantation-52861https://curecurrent.com/trials/laboratory-treated-autologous-lymphocytes-aldesleukin-and-gm-csf-in-treating-patients-with-recurrent-refractory-or-metas-52862https://curecurrent.com/trials/endostar-continued-pumping-into-vein-combining-with-gemcitabine-carboplatin-to-treat-non-small-cell-lung-cancer-nsclc-52863https://curecurrent.com/trials/rh-endostatin-in-combination-with-icotinib-for-advanced-nsclc-with-egfr-mutations-52864https://curecurrent.com/trials/battle-program-zd6474-in-previously-treated-subjects-with-nsclc-52865https://curecurrent.com/trials/phase-i-igart-study-using-active-breathing-control-and-simultaneous-boost-for-patients-with-nsclc-52866https://curecurrent.com/trials/a-feasibility-trial-using-lithium-as-a-neuroprotective-agent-in-patients-undergoing-prophylactic-cranial-irradiation-for-52867https://curecurrent.com/trials/preoperative-or-postoperative-therapy-of-patients-with-stages-ib-ii-iiia-non-small-cell-lung-cancer-52868https://curecurrent.com/trials/icotinib-and-arsenic-trioxide-in-treating-non-small-cell-lung-cancer-patients-with-resistance-to-egfr-tki-52869https://curecurrent.com/trials/gefitinib-combined-with-thalidomide-to-treat-nsclc-52870https://curecurrent.com/trials/a-phase-i-ii-clinical-trial-of-vorinostat-in-combination-with-erlotinib-for-patients-with-relapsed-refractory-non-small-52871https://curecurrent.com/trials/a-prospective-longitudinal-collection-of-subjects-diagnosed-with-small-cell-lung-cancer-52872https://curecurrent.com/trials/icotinib-in-previously-treated-non-light-smoking-patients-with-advanced-squamous-cell-lung-cancer-52873https://curecurrent.com/trials/study-of-ilx651-in-patients-with-locally-advanced-or-metastatic-non-small-cell-lung-carcinoma-52874https://curecurrent.com/trials/reducing-symptom-burden-non-small-cell-lung-cancer-nsclc-52875https://curecurrent.com/trials/health-outcomes-and-costs-hoc-in-lung-cancer-lc-52876https://curecurrent.com/trials/lymphocyte-profiles-and-activation-status-in-patients-with-graft-versus-host-disease-52877https://curecurrent.com/trials/study-of-vintafolide-mk-8109-ec145-in-participants-with-progressive-adenocarcinoma-of-the-lung-mk-8109-008-ec-fv-03-52878https://curecurrent.com/trials/erlotinib-pharmacokinetics-during-doxycycline-treatment-for-erlotinib-induced-rash-52879https://curecurrent.com/trials/a-study-of-management-of-tarceva-induced-rash-in-patients-with-non-small-cell-lung-cancer-52880https://curecurrent.com/trials/a-study-of-erlotinib-tarceva-versus-gemcitabine-cisplatin-as-first-line-treatment-in-patients-with-non-small-cell-lung-c-52881https://curecurrent.com/trials/residual-hypermethylation-in-early-stage-non-small-cell-lung-cancer-nsclc-as-part-of-adjuvant-therapy-and-preventive-str-52882https://curecurrent.com/trials/pazopanib-in-treating-patients-with-malignant-pleural-mesothelioma-52883https://curecurrent.com/trials/ecteinascidin-743-in-treating-patients-with-malignant-mesothelioma-52884https://curecurrent.com/trials/phase-ii-study-evaluating-the-safety-and-response-to-neoadjuvant-dasatinib-in-early-stage-non-small-cell-lung-cancer-52885https://curecurrent.com/trials/a-study-of-tarceva-erlotinib-and-standard-of-care-chemotherapy-in-patients-with-advanced-recurrent-or-metastatic-non-sma-52886https://curecurrent.com/trials/a-study-of-mdx-1106-in-patients-with-selected-refractory-or-relapsed-malignancies-52887https://curecurrent.com/trials/shrinking-target-adaptive-radiotherapy-for-locally-advanced-non-small-cell-lung-cancer-52888https://curecurrent.com/trials/a-computer-based-intervention-for-distance-caregivers-of-parents-with-advanced-cancer-52889https://curecurrent.com/trials/erlotinib-hydrochloride-in-preventing-cancer-in-patients-with-precancerous-lesions-of-the-lung-52890https://curecurrent.com/trials/therapeutic-strategy-in-advanced-bronchioloalveolar-carcinoma-52891https://curecurrent.com/trials/nsclc-relapse-therapy-after-surgery-and-peri-operative-chemotherapy-52892https://curecurrent.com/trials/randomised-study-of-concomitant-radiochemotherapy-in-non-small-cell-lung-cancer-52893https://curecurrent.com/trials/lung-cancer-nurse-model-a-phase-ii-study-52894https://curecurrent.com/trials/lobectomy-and-mediastinal-radiochemotherapy-in-unresectable-stage-iii-non-small-cell-lung-cancer-responding-to-induction-52895https://curecurrent.com/trials/a-phase-ii-study-of-doxorubicin-cyclophosphamide-and-vindesine-with-valproic-acid-in-patients-with-refractory-or-relapsi-52896https://curecurrent.com/trials/powered-echelon-device-in-vats-surgery-52897https://curecurrent.com/trials/erlotinib-100mg-or-150mg-in-treating-egfr-mutated-nsclc-52898https://curecurrent.com/trials/randomized-study-of-cisplatin-etoposide-versus-an-etoposide-regimen-without-cisplatin-in-extensive-small-cell-lung-cance-52899https://curecurrent.com/trials/phase-ii-study-of-valproate-and-doxorubicin-in-malignant-mesothelioma-52900https://curecurrent.com/trials/endobronchial-ultrasound-guided-transbronchial-aspiration-ebus-tbna-in-non-small-cell-lung-cancer-nsclc-in-a-tuberculosi-52901https://curecurrent.com/trials/a-study-of-tarceva-erlotinib-following-platinum-based-chemotherapy-in-patients-with-advanced-recurrent-or-metastatic-non-52902https://curecurrent.com/trials/a-safety-and-efficacy-study-of-carboplatin-paclitaxel-bevacizumab-and-ca4p-in-non-small-cell-lung-cancer-52903https://curecurrent.com/trials/simultaneous-cbct-acquisition-during-arc-radiotherapy-52904https://curecurrent.com/trials/s9925-collecting-and-storing-samples-from-patients-with-lung-cancer-52905https://curecurrent.com/trials/detection-of-chromosomal-aberrations-in-non-small-cell-lung-cancer-nsclc-using-fluorescent-in-situ-hybridization-fish-al-52906https://curecurrent.com/trials/effect-of-ccrt-on-respiratory-performance-and-functional-capacity-in-esophagus-cancer-patients-52907https://curecurrent.com/trials/zoledronic-acid-and-positron-emission-tomography-in-treating-patients-with-advanced-non-small-cell-lung-cancer-52908https://curecurrent.com/trials/phase-i-study-of-lbh589-erlotinib-for-advanced-aerodigestive-tract-cancers-52909https://curecurrent.com/trials/mri-optimization-study-in-stage-iii-nsclc-52910https://curecurrent.com/trials/endostar-combination-with-chemotherapy-and-egfr-tki-in-lung-cancer-rechallenging-treatment-after-acquired-resistance-52911https://curecurrent.com/trials/a-prospective-observational-study-to-evaluate-acute-kidney-injury-biomarkers-in-patients-receiving-first-cycle-of-cispla-52912https://curecurrent.com/trials/vats-major-lung-resection-for-chinese-early-stage-non-small-cell-lung-cancer-52913https://curecurrent.com/trials/modified-video-assisted-thoracoscopic-surgery-vats-lobectomy-for-early-stage-non-small-cell-lung-cancer-nsclc-52914https://curecurrent.com/trials/erlotinib-plus-pemetrexed-to-treat-lung-adenocarcinoma-with-brain-metastases-52915https://curecurrent.com/trials/comparator-controlled-study-for-egfr-patients-with-multiple-bms-from-nsclc-broke-egfr-epidermal-growth-factor-receptor-b-52916https://curecurrent.com/trials/an-dose-escalation-trial-of-oral-bibf-1120-in-combination-with-intravenous-carboplatin-and-vinorelbine-in-elderly-patien-52917https://curecurrent.com/trials/neoadjuvant-pemetrexed-carboplatin-and-bevacizumab-in-unresectable-locally-advanced-lung-adenocarcinoma-52918https://curecurrent.com/trials/a-study-of-ridaforolimus-in-non-small-cell-lung-cancer-nsclc-patients-with-kirsten-rat-sarcoma-viral-oncogene-homolog-kr-52919https://curecurrent.com/trials/effect-of-imn1207-versus-casein-on-weight-loss-survival-and-quality-of-life-in-non-small-cell-lung-cancer-patients-52920https://curecurrent.com/trials/effects-of-inspiratory-muscle-training-after-lung-cancer-surgery-a-randomized-controlled-trial-52921https://curecurrent.com/trials/a-3rd-4th-line-placebo-controlled-trial-of-sorafenib-in-patients-with-predominantly-non-squamous-non-small-cell-lung-can-52922https://curecurrent.com/trials/a-study-to-test-lung-function-after-radiation-therapy-52923https://curecurrent.com/trials/a-study-of-verutex-fusidic-acid-eritex-erythromycin-and-fisiogel-in-the-management-of-tarceva-associated-rash-52924https://curecurrent.com/trials/lux-lung-4-bibw-2992-afatinib-phase-i-trial-in-advanced-non-small-cell-lung-cancer-patients-phase-ii-trial-in-non-small-52925https://curecurrent.com/trials/a-study-of-tarceva-erlotinib-in-combination-with-platinum-based-chemotherapy-in-patients-with-non-small-cell-lung-cancer-52926https://curecurrent.com/trials/a-study-for-patients-with-egfrm-epidermal-growth-factor-receptor-mutant-lung-cancer-52927https://curecurrent.com/trials/identification-of-a-plasma-proteomic-signature-for-lung-cancer-52928https://curecurrent.com/trials/a-study-of-mgcd265-given-with-erlotinib-or-docetaxel-in-subjects-with-advanced-malignancies-or-non-small-cell-lung-cance-52929https://curecurrent.com/trials/prevalence-of-malignant-and-premalignant-lesions-in-the-head-neck-in-patients-with-chronic-obstructive-pulmonary-disease-52930https://curecurrent.com/trials/e7389-in-treating-patients-with-recurrent-or-progressive-stage-iiib-or-stage-iv-non-small-cell-lung-cancer-52931https://curecurrent.com/trials/gefitinib-in-treating-patients-with-stage-ib-ii-or-iiia-non-small-cell-lung-cancer-that-was-completely-removed-by-surger-52932https://curecurrent.com/trials/study-observational-of-erlotinib-as-second-line-treatment-in-patients-with-squamous-nsclc-and-egfr-native-52933https://curecurrent.com/trials/bortezomib-in-treating-patients-with-malignant-pleural-mesothelioma-52934https://curecurrent.com/trials/panobinostat-etoposide-and-cisplatin-as-first-line-therapy-in-treating-patients-with-extensive-stage-small-cell-lung-can-52935https://curecurrent.com/trials/safety-and-efficacy-of-rad001-in-chinese-patients-with-advanced-pulmonary-neuroendocrine-tumor-52936https://curecurrent.com/trials/dose-escalation-of-icotinib-in-advanced-non-small-cell-lung-carcinoma-nsclc-patients-evaluated-as-stable-disease-52937https://curecurrent.com/trials/intrathecal-bolus-doses-of-ziconotide-52938https://curecurrent.com/trials/a-trial-on-clinical-efficacy-of-1-versus-2-lignocaine-in-cough-suppression-and-pain-relief-in-patients-undergoing-flexib-52939https://curecurrent.com/trials/phase-ii-study-of-irinotecan-and-cisplatin-in-extensive-stage-small-cell-lung-cancer-52940https://curecurrent.com/trials/a-study-of-ramucirumab-imc-1121b-with-paclitaxel-and-carboplatin-in-non-small-cell-lung-cancer-52941https://curecurrent.com/trials/pemetrexed-and-best-supportive-care-versus-placebo-and-best-supportive-care-in-non-small-cell-lung-cancer-nsclc-52942https://curecurrent.com/trials/ponatinib-for-squamous-cell-lung-and-head-and-neck-cancers-52943https://curecurrent.com/trials/application-of-diffusion-weighted-mri-versus-ct-in-evaluation-of-the-effect-of-treating-lung-cancer-52944https://curecurrent.com/trials/erlotinib-with-concurrent-brain-radiotherapy-and-secondary-brain-radiotherapy-after-recurrence-with-erlotinib-in-nsclc-n-52945https://curecurrent.com/trials/advance-care-planning-a-way-to-improve-end-of-life-care-life-care-52946https://curecurrent.com/trials/a-study-of-tarceva-erlotinib-in-patients-with-advanced-non-small-cell-lung-cancer-naive-to-chemotherapy-52947https://curecurrent.com/trials/consolidation-chemotherapy-concurrent-chemo-radiotherapy-for-inoperable-stage-iii-non-small-cell-lung-cancer-nsclc-52948https://curecurrent.com/trials/gefitinib-plus-vinorelbine-in-advanced-egfr-mutated-nsclc-genoa-trial-52949https://curecurrent.com/trials/screening-for-early-lung-cancer-in-shanghai-china-52950https://curecurrent.com/trials/extended-out-of-hospital-low-molecular-weight-heparin-prophylaxis-against-dvt-and-pe-in-patients-undergoing-major-lung-r-52951https://curecurrent.com/trials/personalized-therapy-in-non-small-cell-lung-cancer-52952https://curecurrent.com/trials/safety-and-efficacy-study-of-a-new-chemotherapy-agent-to-treat-non-small-cell-lung-cancer-52953https://curecurrent.com/trials/erlotinib-as-first-line-treatment-of-advanced-non-small-cell-lung-cancer-nsclc-for-patients-unfit-for-chemotherapy-52954https://curecurrent.com/trials/utility-of-routine-cervical-mediastinoscopy-in-clinical-stage-i-non-small-cell-lung-cancer-nsclc-52955https://curecurrent.com/trials/support-needs-and-preferences-of-family-caregivers-of-lung-cancer-patients-52956https://curecurrent.com/trials/improving-end-of-life-care-by-continuing-medical-education-and-electronic-decision-making-support-for-general-practition-52957https://curecurrent.com/trials/prospective-observational-study-to-evaluate-biomarkers-of-aminoglycoside-nephrotoxicity-in-patients-with-cystic-fibrosis-52958https://curecurrent.com/trials/stereotactic-precision-and-conventional-radiotherapy-evaluation-52959https://curecurrent.com/trials/phase-ii-randomized-study-on-locally-advanced-nsclc-escalated-dose-on-individual-basis-treatment-with-radiochemotherapy-52960https://curecurrent.com/trials/study-to-investigate-the-effect-of-aprotinin-of-transfusion-requirements-in-patients-undergoing-surgical-procedures-for-52961https://curecurrent.com/trials/phase-iv-study-of-tarceva-in-patients-with-advanced-stage-iiib-iv-non-small-cell-lung-cancer-nsclc-52962https://curecurrent.com/trials/bevacizumab-in-combination-with-chemotherapy-in-patients-with-advanced-or-recurrent-non-squamous-nsclc-52963https://curecurrent.com/trials/study-of-use-of-pemetrexed-in-patients-with-non-small-lung-cancer-metastatic-in-andalusian-public-health-system-52964https://curecurrent.com/trials/incidence-and-patterns-of-nausea-vomiting-with-combined-chemotherapy-and-radiation-52965https://curecurrent.com/trials/hemodynamic-changes-during-one-lung-ventilation-in-non-intubated-vedio-assisted-thoracoscopic-operations-52966https://curecurrent.com/trials/safety-and-efficacy-study-of-a-new-chemotherapy-agent-to-treat-non-small-cell-lung-cancer-52967https://curecurrent.com/trials/first-line-chemotherapy-and-panitumumab-in-advanced-non-small-cell-lung-cancer-52968https://curecurrent.com/trials/erlotinib-in-treating-patients-with-stage-iii-or-stage-iv-non-small-cell-lung-cancer-52969https://curecurrent.com/trials/etoposide-and-cisplatin-or-carboplatin-as-first-line-chemotherapy-with-or-without-pravastatin-in-treating-patients-with-52970https://curecurrent.com/trials/efficiency-of-diagnostic-strategy-for-fast-track-lung-cancer-diagnosis-52971https://curecurrent.com/trials/cisplatin-vinorelbine-and-radiation-therapy-in-treating-patients-with-stage-iii-non-small-cell-lung-cancer-that-cannot-b-52972https://curecurrent.com/trials/long-term-treatment-for-cancer-patients-with-deep-venous-thrombosis-or-pulmonary-embolism-52973https://curecurrent.com/trials/molecular-predictors-of-pemetrexed-and-carboplatin-response-in-malignant-pleural-mesothelioma-mpm-patients-52974https://curecurrent.com/trials/communicating-smoking-risks-through-graphic-warning-labels-52975https://curecurrent.com/trials/belotecan-and-cisplatin-in-treating-patients-with-previously-untreated-extensive-stage-small-cell-lung-cancer-52976https://curecurrent.com/trials/phase-ii-study-of-gefitinib-plus-nimotuzumab-versus-gefitinib-in-non-small-cell-lung-cancer-52977https://curecurrent.com/trials/identification-of-egfr-tkis-sensitivity-or-resistance-markers-in-nsclc-may-help-in-optimal-patient-selection-52978https://curecurrent.com/trials/study-of-sequential-topoisomerase-irinotecan-oxaliplatin-etoposide-carboplatin-in-extensive-small-cell-lung-cancer-sclc-52979https://curecurrent.com/trials/customized-neoadjuvant-versus-standard-chemotherapy-in-nscl-patients-with-resectable-stage-iiia-n2-disease-52980https://curecurrent.com/trials/study-of-everolimus-pemetrexed-carboplatin-and-bevacizumab-to-treat-stage-iv-lung-cancer-52981https://curecurrent.com/trials/amifostine-in-treating-patients-with-stage-ii-or-stage-iii-non-small-cell-lung-cancer-52982https://curecurrent.com/trials/a-clinical-trial-of-adi-peg-20tm-in-patients-with-malignant-pleural-mesothelioma-52983https://curecurrent.com/trials/monotherapy-pazopanib-in-subjects-with-advanced-non-small-cell-lung-cancer-52984https://curecurrent.com/trials/a-study-of-avastin-bevacizumab-in-patients-with-non-squamous-non-small-cell-lung-cancer-with-asymptomatic-untreated-brai-52985https://curecurrent.com/trials/sorafenib-cisplatin-and-etoposide-in-treating-patients-with-extensive-stage-small-cell-lung-cancer-52986https://curecurrent.com/trials/retrospective-study-in-non-small-cell-lung-cancer-nsclc-with-epidermal-growth-factor-receptor-egfr-52987https://curecurrent.com/trials/mindfulness-therapy-for-individuals-with-lung-cancer-52988https://curecurrent.com/trials/combination-of-gp96-ig-vaccine-theophylline-and-oxygen-for-the-treatment-of-patients-with-advanced-relapsed-or-metastati-52989https://curecurrent.com/trials/phase-1b-2-study-of-retaspimycin-hcl-ipi-504-in-combination-with-everolimus-in-kras-mutant-non-small-cell-lung-cancer-52990https://curecurrent.com/trials/a-proof-of-principle-study-of-aminolevulinic-acid-ala-induced-fluorescence-detection-in-resectable-non-small-cell-lung-c-52991https://curecurrent.com/trials/comparison-of-different-types-of-surgery-in-treating-patients-with-early-stage-non-small-cell-lung-cancer-52992https://curecurrent.com/trials/a-study-of-tarceva-erlotinib-in-combination-with-avastin-bevacizumab-in-patients-with-advanced-non-small-cell-lung-cance-52993https://curecurrent.com/trials/mk-0646-insulin-growth-factor-1-receptor-antibody-in-stage-iiib-or-iv-metastatic-non-squamous-lung-cancer-52994https://curecurrent.com/trials/evaluation-of-4d-contrast-enhanced-pet-ct-in-tumour-volume-definition-52995https://curecurrent.com/trials/the-comparative-study-on-rh-endostatin-endostar-continuous-intravenous-infusion-and-routine-i-v-in-combination-with-gp-r-52996https://curecurrent.com/trials/high-dose-pemetrexed-to-treat-lung-adenocarcinoma-with-brain-metastases-52997https://curecurrent.com/trials/icotinib-as-the-adjunctive-treatment-after-surgery-in-stage-i-iiib-lung-adenocarcinoma-patients-with-egfr-gene-mutation-52998https://curecurrent.com/trials/value-of-physical-capacity-tests-in-lung-cancer-52999https://curecurrent.com/trials/a-study-of-a-new-chemotherapy-agent-in-combination-with-cisplatin-to-treat-small-cell-lung-cancer-53000